COENZYME Q10: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Abe, K., Matsuo, Y., Kadekawa, J., Inoue, S., and Yanagihara, T. Effect of coenzyme Q10 in patients with mitochondrial myopathy, brain disorder, lactic acidosis, and stroke-like episodes ( MELAS ) : evaluation by noninvasive tissue oximetry. J Neurol.Sci. 1-1-1999 ; 162 ( 1 ) :65-68. View outline. Ahn, J. H., Yoo, M. H., Lee, H. J., Chung, J. W., and Yoon, T. H. Coenzyme Q10 in combination with steroid hormone therapy for discussion of sudden sensorineural hear loss : a control prospective cogitation. Clin Otolaryngol. 2010 ; 35 ( 6 ) :486-489. View pilfer. Amadio E, Palermo R Peloni G Littarru G. Effect of CoQ10 administration on V02max and diastolic function in athletes. Biomedical and clinical aspects of Coenzyme Q10. 1991 ; 525-533. Aoki S and Yamaguchi K. [ Clinical experiences in use of cinnarizine and CoQ10 for discussion of sensorineural tinnitus ]. Shinyaku to Rinsho 1970 ; 29:1541-1546.

Armstrong, M. J. and Miyasaki, J. M. Evidence-based guidepost : pharmacological discussion of chorea in Huntington disease : report card of the guidepost development subcommittee of the American Academy of Neurology. Neurology 8-7-2012 ; 79 ( 6 ) :597-603. View abstract. Artuch, R., Brea-Calvo, G., Briones, P., Aracil, A., Galvan, M., Espinos, C., Corral, J., Volpini, V., Ribes, A., Andreu, A. L., Palau, F., Sanchez-Alcazar, J. A., Navas, P., and Pineda, M. Cerebellar ataxia with coenzyme Q10 insufficiency : diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol.Sci 7-15-2006 ; 246 ( 1-2 ) :153-158. View abstract. Aure, K., Benoist, J. F., Ogier, de Baulny, Romero, N. B., Rigal, O., and Lombes, A. Progression despite successor of a myopathic imprint of coenzyme Q10 defect. Neurology 8-24-2004 ; 63 ( 4 ) :727-729. View abstract. Azevedo, O., Vilarinho, L., Almeida, F., Ferreira, F., Guardado, J., Ferreira, M., Lourenco, A., Medeiros, R., and Almeida, J. Cardiomyopathy and kidney disease in a patient with maternally inherited diabetes and deafness caused by the 3243A > G mutation of mitochondrial DNA. Cardiology 2010 ; 115 ( 1 ) :71-74. View pilfer. Baggio, E., Gandini, R., Plancher, A. C., Passeri, M., and Carmosino, G. Italian multicenter study on the base hit and efficacy of coenzyme Q10 as adjunctive therapy in heart failure ( interim analysis ). The CoQ10 Drug Surveillance Investigators. Clin Investig. 1993 ; 71 ( 8 Suppl ) : S145-S149. View abstract. Balercia G, Arnaldi G, Lucarelli G, and et alabama. Effects of exogenous CoQ10 administration in patients with idiopathic asthenozoospermia. International Journal of Andrology 2000 ; Suppl 23:43. Balercia, G., Buldreghini, E., Vignini, A., Tiano, L., Paggi, F., Amoroso, S., Ricciardo-Lamonica, G., Boscaro, M., Lenzi, A., and Littarru, G. Coenzyme Q10 discussion in sterile men with idiopathic asthenozoospermia : a placebo-controlled, double-blind randomized trial. Fertil.Steril. 2009 ; 91 ( 5 ) :1785-1792. View abstract. Balercia, G., Mancini, A., Paggi, F., Tiano, L., Pontecorvi, A., Boscaro, M., Lenzi, A., and Littarru, G. P. Coenzyme Q10 and male sterility. J Endocrinol Invest 2009 ; 32 ( 7 ) :626-632. View outline. Barbiroli, B., Frassineti, C., Martinelli, P., Iotti, S., Lodi, R., Cortelli, P., and Montagna, P. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and bony muscle by phosphorous magnetic plangency spectroscopy. Cell Mol.Biol ( Noisy.-le-grand ) 1997 ; 43 ( 5 ) :741-749. View abstraction. Barbiroli, B., Iotti, S., and Lodi, R. Improved brain and brawn mitochondrial breathing with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies. Biofactors 1999 ; 9 ( 2-4 ) :253-260. View outline. Barbiroli, B., Iotti, S., Cortelli, P., Martinelli, P., Lodi, R., Carelli, V., and Montagna, P. Low brain intracellular free magnesium in mitochondrial cytopathies. J Cereb.Blood Flow Metab 1999 ; 19 ( 5 ) :528-532. View abstract. Barboni, P., Valentino, M. L., La, Morgia C., Carbonelli, M., Savini, G., De, Negri A., Simonelli, F., Sadun, F., Caporali, L., Maresca, A., Liguori, R., Baruzzi, A., Zeviani, M., and Carelli, V. Idebenone discussion in patients with OPA1-mutant dominant eye atrophy. Brain 2013 ; 136 ( Pt 2 ) : e231. View abstract. Barker, P. D. Reduced G allowance associated with supplement practice. Aviat.Space Environ.Med 2011 ; 82 ( 2 ) :140-143. View abstract. Beal, M. F. Therapeutic approaches to mitochondrial dysfunction in Parkinson ‘s disease. Parkinsonism.Relat Disord. 2009 ; 15 Suppl 3 : S189-S194. View abstract. Belaia, O. L., Kalmykova, V. I., Ivanova, L. A., and Kochergina, L. G. [ Experience in coenzyme Q10 application in complex therapy of coronary center disease with dyslipidemia ]. Klin Med ( Mosk ) 2006 ; 84 ( 5 ) :59-62. View abstract. Belcaro, G., Cesarone, M. R., Dugall, M., Hosoi, M., Ippolito, E., Bavera, P., and Grossi, M. G. Investigation of Pycnogenol ( R ) in combination with coenzymeQ10 in center failure patients ( NYHA II/III ). Panminerva Med 2010 ; 52 ( 2 Suppl 1 ) :21-25. View abstract. Bentov, Y., Esfandiari, N., Burstein, E., and Casper, R. F. The use of mitochondrial nutrients to improve the consequence of sterility treatment in older patients. Fertil.Steril. 2010 ; 93 ( 1 ) :272-275. View abstract. Bergamin, C. S., Rolim, L. C., Dib, S. A., and Moises, R. S. Unusual happening of intestinal imposter obstruction in a patient with maternally inherited diabetes and deafness ( MIDD ) and golden consequence with coenzyme Q10. Arq Bras.Endocrinol Metabol. 2008 ; 52 ( 8 ) :1345-1349. View abstract. Berio, A. and Piazzi, A. improvement of Kearns-Sayre syndrome with control carbohydrate inhalation and coenzyme Q10 therapy. Ophthalmologica 1994 ; 208 ( 6 ) :342-343. View abstract. Bessler, H., Bergman, M., Blumberger, N., Djaldetti, M., and Salman, H. Coenzyme Q10 decreases TNF-alpha and IL-2 secretion by human peripheral blood mononuclear cells. J Nutr Sci Vitaminol. ( Tokyo ) 2010 ; 56 ( 1 ) :77-81. View abstract. Beyer RE, Nordenbrand K, and Ernster L. The function of coenzyme Q in dislodge radical output and as an antioxidant : a review. Chemica Scripta 1987 ; 27:145-153. Blatt, T., Mundt, C., Mummert, C., Maksiuk, T., Wolber, R., Keyhani, R., Schreiner, V., Hoppe, U., Schachtschabel, D. O., and Stab, F. [ Modulation of oxidative stresses in homo aging skin ]. Z.Gerontol.Geriatr. 1999 ; 32 ( 2 ) :83-88. View abstraction. Bloomer, R. J., Canale, R. E., McCarthy, C. G., and Farney, T. M. Impact of oral ubiquinol on blood oxidative stress and exercise performance. Oxid.Med.Cell Longev. 2012 ; 2012:465020. View pilfer. Bolognesi, M. L., Matera, R., Minarini, A., Rosini, M., and Melchiorre, C. Alzheimer ‘s disease : new approaches to drug discovery. Curr Opin.Chem Biol. 2009 ; 13 ( 3 ) :303-308. View abstract. Bookstaver, D. A., Burkhalter, N. A., and Hatzigeorgiou, C. Effect of coenzyme Q10 supplement on statin-induced myalgia. Am.J.Cardiol. 8-15-2012 ; 110 ( 4 ) :526-529. View abstract. Braun, B., Clarkson, P. M., Freedson, P. S., and Kohl, R. L. Effects of coenzyme Q10 supplementation on exercise performance, VO2max, and lipid peroxidation in educate cyclists. Int J Sport Nutr. 1991 ; 1 ( 4 ) :353-365. View abstract. Bresolin N, Cossutta E, Angelini C, and et alabama. fifty patients with mitochondrial myopathy treated with ubidecarenone. First multicentric study. J Neurology 1988 ; 235 : S79. Bresolin, N., Bet, L., Binda, A., Moggio, M., Comi, G., Nador, F., Ferrante, C., Carenzi, A., and Scarlato, G. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10. Neurology 1988 ; 38 ( 6 ) :892-899. View abstract. Bresolin, N., Bet, L., Ferrante, C., Binda, A., Carenzi, A., Moggio, M., Comi, G., and Scarlato, G. Immunological and biochemical studies and original curative trial with ubidecarenone in Kearns-Sayre patients. Adv Neurol 1988 ; 48:239-256. View abstract. Brookman, R. H. and St Cyr, J. A. Metabolic supplement with enhanced external counterpulsation improves myocardial function in acquired cardiomyopathy : a sheath reputation. J Altern.Complement Med 2010 ; 16 ( 3 ) :323-325. View abstract. Buyse, G. M., Goemans, N., van hideout Hauwe, M., Thijs, D., de Groot, I. J., Schara, U., Ceulemans, B., Meier, T., and Mertens, L. Idebenone as a fresh, curative approach for Duchenne brawny dystrophy : results from a 12 calendar month, double-blind, randomized placebo-controlled trial. Neuromuscul.Disord. 2011 ; 21 ( 6 ) :396-405. View abstract. Cadoni, G., Scorpecci, A., Cianfrone, F., Giannantonio, S., Paludetti, G., and Lippa, S. Serum fatso acids and cardiovascular risk factors in sudden sensorineural listen loss : a case-control study. Ann Otol.Rhinol.Laryngol. 2010 ; 119 ( 2 ) :82-88. View abstract. Caramia, G., Cocchi, M., Tonello, L., and Visci, G. [ Childhood fleshiness : recent advances and an experimental contribution ]. Pediatr Med Chir 2008 ; 30 ( 3 ) :121-140. View abstraction. Celik, T. and Iyisoy, A. Coenzyme Q10 and coronary artery bypass surgery : what we have learned from clinical trials. J Cardiothorac.Vasc.Anesth. 2009 ; 23 ( 6 ) :935-936. View abstract. Centre for Reviews and Dissemination. Idebenone ( SNT-MC17 ) for Friedreich ‘s ataxia : horizon scanning engineering briefing ( Project record ). 2013 ; Chen, J. J. Parkinson ‘s disease : health-related timbre of life, economic cost, and implications of early treatment. Am J Manag.Care 2010 ; 16 Suppl Implications : S87-S93. View abstract. Chen, Y. F., Lin, Y. T., and Wu, S. C. Effectiveness of coenzyme Q10 on myocardial conservation during hypothermic cardioplegic arrest. J Thorac.Cardiovasc.Surg. 1994 ; 107 ( 1 ) :242-247. View abstraction. Chew, G. T., Watts, G. F., Davis, T. M., Stuckey, B. G., Beilin, L. J., Thompson, P. L., Burke, V., and Currie, P. J. Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with exit ventricular diastolic dysfunction. Diabetes Care 2008 ; 31 ( 8 ) :1502-1509. View outline. Chinnery, P., Majamaa, K., Turnbull, D., and Thorburn, D. Treatment for mitochondrial disorders. Cochrane Database Syst.Rev. 2006 ; ( 1 ) : CD004426. View abstraction. Chopra, R. K., Goldman, R., Sinatra, S. T., and Bhagavan, H. N. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vitam.Nutr Res 1998 ; 68 ( 2 ) :109-113. View abstract. Cicero, A. F., Derosa, G., Miconi, A., Laghi, L., Nascetti, S., and Gaddi, A. possible character of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. Biomed Pharmacother 2005 ; 59 ( 6 ) :312-317. View abstraction. Cooney, R. V., Dai, Q., Gao, Y. T., Chow, W. H., Franke, A. A., Shu, X. O., Li, H., Ji, B., Cai, Q., Chai, W., and Zheng, W. Low plasma coenzyme Q ( 10 ) levels and front cancer hazard in chinese women. Cancer Epidemiol Biomarkers Prev. 2011 ; 20 ( 6 ) :1124-1130. View abstract. Cooper, J. M., Korlipara, L. V., Hart, P. E., Bradley, J. L., and Schapira, A. H. Coenzyme Q10 and vitamin E lack in Friedreich ‘s ataxia : predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur.J Neurol. 2008 ; 15 ( 12 ) :1371-1379. View pilfer. Cordero, M. D., Alcocer-Gomez, E., de, Miguel M., Cano-Garcia, F. J., Luque, C. M., Fernandez-Riejo, P., Fernandez, A. M., and Sanchez-Alcazar, J. A. Coenzyme Q ( 10 ) : a fresh curative approach for Fibromyalgia ? case serial with 5 patients. Mitochondrion. 2011 ; 11 ( 4 ) :623-625. View abstract. Cordero, M. D., Cotan, D., del-Pozo-Martin, Y., Carrion, A. M., de, Miguel M., Bullon, P., and Sanchez-Alcazar, J. A. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in lineage mononuclear cells in a fibromyalgia patient. nutrition 2012 ; 28 ( 11-12 ) :1200-1203. View abstract. Cordero, M. D., de, Miguel M., Moreno Fernandez, A. M., Carmona Lopez, I. M., Garrido, Maraver J., Cotan, D., Gomez, Izquierdo L., Bonal, P., Campa, F., Bullon, P., Navas, P., and Sanchez Alcazar, J. A. Mitochondrial dysfunction and mitophagy activation in rake mononuclear cells of fibromyalgia patients : implications in the pathogenesis of the disease. Arthritis Res Ther 2010 ; 12 ( 1 ) : R17. View abstract. Cordero, M. D., Moreno-Fernandez, A. M., Carmona-Lopez, M. I., Sanchez-Alcazar, J. A., Rodriguez, A. F., Navas, P., and de, Miguel M. Mitochondrial dysfunction in bark biopsies and blood mononuclear cells from two cases of fibromyalgia patients. Clin Biochem 2010 ; 43 ( 13-14 ) :1174-1176. View abstract. Cornelli, U. treatment of Alzheimer ‘s disease with a cholinesterase inhibitor combined with antioxidants. Neurodegener.Dis 2010 ; 7 ( 1-3 ) :193-202. View abstract. Cortes, E. P., Gupta, M., Chou, C., Amin, V. C., and Folkers, K. Adriamycin cardiotoxicity : early signal detection by systolic time interval and possible prevention by coenzyme Q10. Cancer Treat.Rep. 1978 ; 62 ( 6 ) :887-891. View abstract. Costeff, H., Apter, N., Elpeleg, O. N., Prialnic, M., and Bohles, H. J. Ineffectiveness of oral coenzyme Q10 supplementation in 3- methylglutaconic aciduria, type 3. Brain Dev. 1998 ; 20 ( 1 ) :33-35. View abstract. Cyrus-Hajmassy, M. [ Bilateral ocular deterioration in excessive tobacco and alcohol consumption ]. Ophthalmologe 2012 ; 109 ( 9 ) :901-906. View abstraction. D’Andrea, G., Bussone, G., Allais, G., Aguggia, M., D’Onofrio, F., Maggio, M., Moschiano, F., Saracco, M. G., Terzi, M. G., Petretta, V., and Benedetto, C. Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol.Sci 2009 ; 30 Suppl 1 : S121-S124. View pilfer. Dai, Y. L., Luk, T. H., Yiu, K. H., Wang, M., Yip, P. M., Lee, S. W., Li, S. W., Tam, S., Fong, B., Lau, C. P., Siu, C. W., and Tse, H. F. Reversal of mitochondrial dysfunction by coenzyme Q10 accessory improves endothelial officiate in patients with ischemic left ventricular systolic dysfunction : a randomize controlled trial. atherosclerosis 2011 ; 216 ( 2 ) :395-401. View abstract. Damian, M. S., Ellenberg, D., Gildemeister, R., Lauermann, J., Simonis, G., Sauter, W., and Georgi, C. Coenzyme Q10 combined with mild hypothermia after cardiac check : a preliminary survey. Circulation 11-9-2004 ; 110 ( 19 ) :3011-3016. View abstract. Deichmann, R. E., Lavie, C. J., and Dornelles, A. C. Impact of coenzyme Q-10 on parameters of cardiopulmonary seaworthiness and muscle performance in older athletes taking statins. Phys.Sportsmed. 2012 ; 40 ( 4 ) :88-95. View abstract. Del Mar, C. B., Glasziou, P. P., Spinks, A. B., and Sanders, S. L. Is coenzyme Q10 helpful for patients with idiopathic cardiomyopathy ? Med J Aust. 4-16-2001 ; 174 ( 8 ) :421. View abstract. Desnuelle, C., Pellissier, J. F., Serratrice, G., Pouget, J., and Turnbull, D. M. [ Kearns-Sayre syndrome : mitochondrial encephalomyopathy caused by lack of the respiratory chain ]. Rev Neurol ( Paris ) 1989 ; 145 ( 12 ) :842-850. View abstraction. Digiesi V, Cantini F, and Brodbeck B. effect of coenzyme Q10 on essential arterial high blood pressure. Current Therapeutic Research 1990 ; 47 ( 5 ) :841-845. Digiesi V, Cantini F, Bisi G, and et aluminum. mechanism of action of coenzyme Q10 in essential high blood pressure. Current Therapeutic Research 1992 ; 51 ( 5 ) :668-672. Disdier, P., Harle, J. R., Figarella-Branger, D., Cherif, A. A., Desnuelle, C., and Weiller, P. J. [ Ptosis and asthenia manifesting a mitochondrial myopathy ]. Rev Med Interne 1992 ; 13 ( 5 ) :381-383. View abstract. Donovan, L. E. and Severin, N. E. Maternally inherited diabetes and deafness in a north american kindred : tips for making the diagnosis and review of unique management issues. J Clin Endocrinol.Metab 2006 ; 91 ( 12 ) :4737-4742. View pilfer. Drinkard, B. E., Keyser, R. E., Paul, S. M., Arena, R., Plehn, J. F., Yanovski, J. A., and Di Prospero, N. A. Exercise capacity and idebenone interposition in children and adolescents with Friedreich ataxia. Arch Phys.Med Rehabil. 2010 ; 91 ( 7 ) :1044-1050. View abstract. Duncan, A. J., Bitner-Glindzicz, M., Meunier, B., Costello, H., Hargreaves, I. P., Lopez, L. C., Hirano, M., Quinzii, C. M., Sadowski, M. I., Hardy, J., Singleton, A., Clayton, P. T., and Rahman, S. A folderal mutation in COQ9 causes autosomal-recessive neonatal-onset chief coenzyme Q10 insufficiency : a potentially treatable form of mitochondrial disease. Am J Hum Genet. 2009 ; 84 ( 5 ) :558-566. View outline. Dunn, S. P., Bleske, B., Dorsch, M., Macaulay, T., Van, Tassell B., and Vardeny, O. Nutrition and heart failure : impact of drug therapies and management strategies. Nutr Clin Pract 2009 ; 24 ( 1 ) :60-75. View abstract. Eiholzer, U., Meinhardt, U., Rousson, V., Petrovic, N., Schlumpf, M., and l’Allemand, D. Developmental profiles in young children with Prader-Labhart-Willi syndrome : effects of weight and therapy with growth hormone or coenzyme Q10. Am J Med Genet.A 4-1-2008 ; 146 ( 7 ) :873-880. View abstract. El-ghoroury, E. A., Raslan, H. M., Badawy, E. A., El-Saaid, G. S., Agybi, M. H., Siam, I., and Salem, S. I. Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus : correlation with glycemic control. Blood Coagul.Fibrinolysis 2009 ; 20 ( 4 ) :248-251. View abstract. Esposito, M. and Carotenuto, M. Ginkgolide B complex efficacy for abbreviated prophylaxis of migraine in school-aged children : an open-label study. Neurol.Sci 9-25-2010 ; View abstract. Esteves, A. R., Arduino, D. M., Swerdlow, R. H., Oliveira, C. R., and Cardoso, S. M. Oxidative stress interest in alpha-synuclein oligomerization in Parkinson ‘s disease cybrids. Antioxid.Redox.Signal. 2009 ; 11 ( 3 ) :439-448. View abstract. Feher, J., Kovacs, B., Kovacs, I., Schveoller, M., Papale, A., and Balacco, Gabrieli C. Improvement of ocular functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica 2005 ; 219 ( 3 ) :154-166. View abstract. Feigin A, Kieburtz K, Como P, and et alabama. An open-label trial of coenzyme Q10 ( CoQ ) in Huntington ‘s disease ( HD ) [ abstract ]. Neurology 1994 ; 44 ( suppl 2 ) : A397-A398. Ferrante, K. L., Shefner, J., Zhang, H., Betensky, R., O’Brien, M., Yu, H., Fantasia, M., Taft, J., Beal, M. F., Traynor, B., Newhall, K., Donofrio, P., Caress, J., Ashburn, C., Freiberg, B., O’Neill, C., Paladenech, C., Walker, T., Pestronk, A., Abrams, B., Florence, J., Renna, R., Schierbecker, J., Malkus, B., and Cudkowicz, M. Tolerance of high-dose ( 3,000 mg/day ) coenzyme Q10 in ALS. Neurology 12-13-2005 ; 65 ( 11 ) :1834-1836. View abstract. Ferrer, M. D., Tauler, P., Sureda, A., Pujol, P., Drobnic, F., Tur, J. A., and Pons, A. A soccer match ‘s ability to enhance lymphocyte capability to produce ROS and induce oxidative damage. Int.J Sport Nutr Exerc.Metab 2009 ; 19 ( 3 ) :243-258. View abstract. Fetoni, A. R., Garzaro, M., Ralli, M., Landolfo, V., Sensini, M., Pecorari, G., Mordente, A., Paludetti, G., and Giordano, C. The monitor role of otoacoustic emissions and oxidative stress markers in the protective effects of antioxidant administration in noise-exposed subjects : a fly cogitation. Med Sci Monit. 2009 ; 15 ( 11 ) : R1-R8. View abstract. Fiorella PL, Bargossi AM Grossi G Motta R Senaldi R Battino M Sassi S Sprovieri G Lubich T. Metabolic effects of coenzyme Q10 discussion in high charge athletes. Biomedical and clinical aspects of Coenzyme Q10 1991 ; 513-520. Fogagnolo, P., Sacchi, M., Ceresara, G., Paderni, R., Lapadula, P., Orzalesi, N., and Rossetti, L. The effects of topical coenzyme Q10 and vitamin E D-alpha-tocopheryl polyethylene ethylene glycol 1000 succinate after cataract surgery : a clinical and in vivo confocal study. Ophthalmologica 2013 ; 229 ( 1 ) :26-31. View pilfer. Folkers K. Critique of coenzyme Q in biochemical and biomedical research and in ten years of clinical research on cardiovascular disease. J Mol Med 2002 ; 2:431-460. Folkers, K. and Wolaniuk, A. research on coenzyme Q10 in clinical music and in immunomodulation. Drugs Exp.Clin Res 1985 ; 11 ( 8 ) :539-545. View outline. Folkers, K., Drzewoski, J., Richardson, P. C., Ellis, J., Shizukuishi, S., and Baker, L. Bioenergetics in clinical medicine. sixteen. decrease of high blood pressure in patients by therapy with coenzyme Q10. Res Commun.Chem Pathol.Pharmacol 1981 ; 31 ( 1 ) :129-140. View pilfer. Folkers, K., Langsjoen, P., and Langsjoen, P. H. Therapy with coenzyme Q10 of patients in kernel failure who are eligible or ineligible for a transplant. Biochem Biophys.Res Commun. 1-15-1992 ; 182 ( 1 ) :247-253. View outline. Folkers, K., Morita, M., and McRee, J., Jr. The activities of coenzyme Q10 and vitamin B6 for immune responses. Biochem Biophys.Res Commun. 5-28-1993 ; 193 ( 1 ) :88-92. View pilfer. Folkers, K., Wolaniuk, J., Simonsen, R., Morishita, M., and Vadhanavikit, S. Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10. Proc.Natl.Acad.Sci U.S.A 1985 ; 82 ( 13 ) :4513-4516. View abstract. Forgionne, G. A. Bovine cartilage, coenzyme Q10, and wheat grass therapy for primary peritoneal cancer. J Altern.Complement Med 2005 ; 11 ( 1 ) :161-165. View abstract. Fujimoto, S., Kurihara, N., Hirata, K., and Takeda, T. Effects of coenzyme Q10 administration on pneumonic function and exercise operation in patients with chronic lung diseases. Clin Investig. 1993 ; 71 ( 8 Suppl ) : S162-S166. View abstract. Fumagalli, S., Fattirolli, F., Guarducci, L., Cellai, T., Baldasseroni, S., Tarantini, F., Di, Bari M., Masotti, G., and Marchionni, N. Coenzyme Q10 terclatrate and creatine in chronic affection failure : a randomize, placebo-controlled, double-blind sketch. Clin Cardiol. 2011 ; 34 ( 4 ) :211-217. View abstraction. Galili, N., Sechman, E. V., Cerny, J., Mehdi, M., Mumtaz, M., Westervelt, P., Maguire, J., and Raza, A. clinical reception of myelodysplastic syndromes patients to discussion with coenzyme Q10. Leuk.Res 2007 ; 31 ( 1 ) :19-26. View abstract. Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A., and Murphy, M. P. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II sketch of hepatitis C patients. Liver Int. 2010 ; 30 ( 7 ) :1019-1026. View abstract. Gazdikova, K., Gvozdjakova, A., Kucharska, J., Spustova, V., Braunova, Z., and Dzurik, R. [ Effect of coenzyme Q10 in patients with kidney diseases ]. Cas.Lek.Cesk. 5-24-2001 ; 140 ( 10 ) :307-310. View abstract. Geng, A., Li, B., and Guo, Y. Effects of dietary L-carnitine and coenzyme Q10 at different auxiliary ages on increase performance and some immune reply in ascites-susceptible broilers. Arch.Anim Nutr. 2007 ; 61 ( 1 ) :50-60. View pilfer. Gerards, M., van hideout Bosch, B., Calis, C., Schoonderwoerd, K., van, Engelen K., Tijssen, M., de, Coo R., van five hundred Kooi, A., and Smeets, H. Nonsense mutations in CABC1/ADCK3 cause progressive cerebellar ataxia and atrophy. Mitochondrion. 2010 ; 10 ( 5 ) :510-515. View outline. Ghiringhelli, G. [ Therapy with ubidecarenone in assorted cardiopathies with and without decompensation. Comparison with a standard therapy ]. Boll.Chim.Farm. 1986 ; 125 ( 3 ) :28S-33S. View abstract. Gini, M., Schiavi, M., and Mazzola, C. [ Ubidecarenone ( coenzyme Q10 ) in the therapy of chronic cor pulmonale ]. Boll.Chim.Farm. 1985 ; 124 ( 4 ) :21S-28S. View abstract. Glover, E. I., Martin, J., Maher, A., Thornhill, R. E., Moran, G. R., and Tarnopolsky, M. A. A randomize trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve 2010 ; 42 ( 5 ) :739-748. View abstract. Goda, S., Hamada, T., Ishimoto, S., Kobayashi, T., Goto, I., and Kuroiwa, Y. Clinical improvement after government of coenzyme Q10 in a affected role with mitochondrial encephalomyopathy. J Neurol. 1987 ; 234 ( 1 ) :62-63. View abstract. Gokbel, H., Gul, I., Belviranl, M., and Okudan, N. The effects of coenzyme Q10 supplementation on performance during repeated bouts of supramaximal practice in sedentary men. J Strength Cond.Res 2010 ; 24 ( 1 ) :97-102. View outline. Gold, R., Seibel, P., Reinelt, G., Schindler, R., Landwehr, P., Beck, A., and Reichmann, H. Phosphorus magnetic plangency spectroscopy in the evaluation of mitochondrial myopathies : results of a 6-month therapy survey with coenzyme Q. Eur.Neurol. 1996 ; 36 ( 4 ) :191-196. View abstract. Golomb, B. A., Kwon, E. K., Koperski, S., and Evans, M. A. Amyotrophic lateral sclerosis-like conditions in possible affiliation with cholesterol-lowering drugs : an analysis of patient reports to the University of California, San Diego ( UCSD ) Statin Effects Study. Drug Saf 2009 ; 32 ( 8 ) :649-661. View abstract. Gottlieb, S. S., Khatta, M., and Fisher, M. L. Coenzyme Q10 and Congestive Heart Failure. Ann.Intern.Med 11-7-2000 ; 133 ( 9 ) :745-746. View outline. Gregersen, N., Andresen, B. S., Pedersen, C. B., Olsen, R. K., Corydon, T. J., and Bross, P. Mitochondrial fatso acerb oxidation defects — remaining challenges. J Inherit.Metab Dis 2008 ; 31 ( 5 ) :643-657. View abstract. Gruber, J., Schaffer, S., and Halliwell, B. The mitochondrial free radical hypothesis of age — where do we stand ? Front Biosci 2008 ; 13:6554-6579. View abstract. Guastini, L., Mora, R., Dellepiane, M., Santomauro, V., Giorgio, M., and Salami, A. water-soluble coenzyme Q10 conceptualization in presbycusis : long-run effects. Acta Otolaryngol. 2011 ; 131 ( 5 ) :512-517. View abstraction. Gul, I., Gokbel, H., Belviranli, M., Okudan, N., Buyukbas, S., and Basarali, K. Oxidative stress and antioxidant defense in plasma after repeated bouts of supramaximal exert : the effect of coenzyme Q10. J Sports Med Phys.Fitness 2011 ; 51 ( 2 ) :305-312. View pilfer. Gutzmann, H., Kuhl, K. P., Hadler, D., and Rapp, M. A. base hit and efficacy of idebenone versus tacrine in patients with Alzheimer ‘s disease : results of a randomized, double-blind, parallel-group multicenter study. Pharmacopsychiatry 2002 ; 35 ( 1 ) :12-18. View abstract. Gvozdjakova A, Kucharska J, Braunova Z, and et alabama. beneficial effect of CoQ10 on the antioxidative condition and metabolism of fats and sugars in diabetic patients. First Conference of the International Coenzyme Q10 Association 2002 ; Gvozdjakova A, Kucharska J, Lepies P, and et alabama. Decreased level of sperm coenzyme Q10, mitochondrial respiration and energy production in sterile patients therapeutic effect on coenzyme Q10 ( a fender report ). First Conference of the International Coenzyme Q10 Association 2002 ; Gvozdjakova, A., Kucharska, J., Bartkovjakova, M., Gazdikova, K., and Gazdik, F. E. Coenzyme Q10 supplementation reduces corticosteroids dose in patients with bronchial asthma. Biofactors 2005 ; 25 ( 1-4 ) :235-240. View abstract. Haginoya, K., Miyabayashi, S., Kikuchi, M., Kojima, A., Yamamoto, K., Omura, K., Uematsu, M., Hino-Fukuyo, N., Tanaka, S., and Tsuchiya, S. Efficacy of idebenone for respiratory failure in a affected role with Leigh syndrome : a long-run follow-up cogitation. J Neurol.Sci 3-15-2009 ; 278 ( 1-2 ) :112-114. View abstraction. Hamilton, S. J., Chew, G. T., and Watts, G. F. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care 2009 ; 32 ( 5 ) :810-812. View abstract. Hanisch, F. and Zierz, S. Only transient increase of serum CoQ subset 10 during long-run CoQ10 therapy in mitochondrial ophthalmoplegia. Eur.J Med.Res 11-12-2003 ; 8 ( 11 ) :485-491. View abstract. Harinstein, M. E., Berliner, J. I., Shah, S. J., Taegtmeyer, H., and Gheorghiade, M. Normalization of expulsion divide and resolution of symptoms in chronic austere heart bankruptcy is possible with modern aesculapian therapy : clinical observations in 11 patients. Am J Ther 2008 ; 15 ( 3 ) :206-213. View abstract. Hart, P. E., Lodi, R., Rajagopalan, B., Bradley, J. L., Crilley, J. G., Turner, C., Blamire, A. M., Manners, D., Styles, P., Schapira, A. H., and Cooper, J. M. Antioxidant treatment of patients with Friedreich ataxia : four-year follow-up. Arch.Neurol. 2005 ; 62 ( 4 ) :621-626. View pilfer. Hauser, R. A. early pharmacological discussion in Parkinson ‘s disease. Am J Manag.Care 2010 ; 16 Suppl Implications : S100-S107. View outline. Henchcliffe, C. and Beal, M. F. Mitochondrial biota and oxidative stress in Parkinson disease pathogenesis. Nat.Clin Pract Neurol. 2008 ; 4 ( 11 ) :600-609. View abstract. Hernandez-Ojeda, J., Cardona-Munoz, E. G., Roman-Pintos, L. M., Troyo-Sanroman, R., Ortiz-Lazareno, P. C., Cardenas-Meza, M. A., Pascoe-Gonzalez, S., and Miranda-Diaz, A. G. The effect of ubiquinone in diabetic polyneuropathy : a randomize double-blind placebo-controlled study. J.Diabetes Complications 2012 ; 26 ( 4 ) :352-358. View abstract. Hertz, N. and Lister, R. E. Improved survival in patients with end-stage cancer treated with coenzyme Q ( 10 ) and other antioxidants : a fender study. J Int.Med Res 2009 ; 37 ( 6 ) :1961-1971. View abstract. Hirano, M., Quinzii, C. M., and DiMauro, S. Restoring balance to ataxia with coenzyme Q10 lack. J Neurol.Sci 7-15-2006 ; 246 ( 1-2 ) :11-12. View abstract. Hoenjet, K. M., Dagnelie, P. C., Delaere, K. P., Wijckmans, N. E., Zambon, J. V., and Oosterhof, G. O. Effect of a nutritional append containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate : a randomized placebo-controlled study. Eur Urol 2005 ; 47 ( 4 ) :433-439. View outline. Horvath, R., Gorman, G., and Chinnery, P. F. How can we treat mitochondrial encephalomyopathies ? Approaches to therapy. Neurotherapeutics. 2008 ; 5 ( 4 ) :558-568. View abstract. Horvath, R., Schneiderat, P., Schoser, B. G., Gempel, K., Neuen-Jacob, E., Ploger, H., Muller-Hocker, J., Pongratz, D. E., Naini, A., DiMauro, S., and Lochmuller, H. Coenzyme Q10 insufficiency and isolate myopathy. Neurology 1-24-2006 ; 66 ( 2 ) :253-255. View pilfer. Iarussi, D., Auricchio, U., Agretto, A., Murano, A., Giuliano, M., Casale, F., Indolfi, P., and Iacono, A. protective effect of coenzyme Q10 on anthracyclines cardiotoxicity : control condition study in children with acute lymphoblastic leukemia and non- Hodgkin lymphoma. Mol.Aspects Med 1994 ; 15 Suppl : s207-s212. View pilfer. Imanaka K, Izumiyama K, and Sakaguchi T et alabama. effect of coenzyme Q10 and azelastin on protecting radiation pneumonitis with lung cancer. Journal of Japan Society for Cancer Therapy 1994 ; 29:2010-2015. Inui, M., Ooe, M., Fujii, K., Matsunaka, H., Yoshida, M., and Ichihashi, M. Mechanisms of inhibitory effects of CoQ10 on UVB-induced wrinkle formation in vitro and in vivo. Biofactors 2008 ; 32 ( 1-4 ) :237-243. View abstract. Ishiyama, T., Morita, Y., Toyama, S., Yamagami, T., and Tsukamoto, N. A clinical study of the effect of coenzyme Q on congestive heart failure. Jpn.Heart J 1976 ; 17 ( 1 ) :32-42. View abstract. Islam, J., Uretsky, B. F., and Sierpina, V. S. Heart failure improvement with CoQ10, Hawthorn, and magnesium in a patient scheduled for cardiac resynchronization-defibrillator therapy : a character study. Explore. ( NY ) 2006 ; 2 ( 4 ) :339-341. View abstract. Isobe, C., Abe, T., and Terayama, Y. Increase in the oxidized/total coenzyme Q-10 proportion in the cerebrospinal fluid of Alzheimer ‘s disease patients. Dement.Geriatr.Cogn Disord. 2009 ; 28 ( 5 ) :449-454. View abstract. Isobe, C., Abe, T., and Terayama, Y. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2’-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson ‘s disease show that mitochondrial oxidative price and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci.Lett. 1-18-2010 ; 469 ( 1 ) :159-163. View abstract. Isobe, C., Abe, T., and Terayama, Y. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2’-deoxyguanosine in the CSF of patients with Alzheimer ‘s disease prove that mitochondrial oxidative damage and/or oxidative DNA wrong contributes to the neurodegenerative process. J Neurol. 2010 ; 257 ( 3 ) :399-404. View abstract. Jacobson, B. H., Smith, D. B., Warren, A. J., Glass, R. G., Kline, C., Fedick, J. L., and Stemm, J. Assessment of the effectiveness of a sublingual, ergogenic spray on muscle military capability and power. J Strength Cond.Res 2009 ; 23 ( 8 ) :2326-2330. View abstract. Jeejeebhoy, F., Keith, M., Freeman, M., Barr, A., McCall, M., Kurian, R., Mazer, D., and Errett, L. Nutritional supplement with MyoVive repletes all-important cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 2002 ; 143 ( 6 ) :1092-1100. View abstract. Jimenez-Caballero, P. E., Mollejo-Villanueva, M., and Alvarez-Tejerina, A. [ Mitochondrial brain disorder due to complex I lack. Brain tissue biopsy findings and clinical course following pharmacological ]. Rev.Neurol. 7-1-2008 ; 47 ( 1 ) :27-30. View abstract. Judy WV, Folkers K, and Hall JH. Improved long-run survival in conezyme Q10 treated chronic heart failure patients compared to conventionally process patients. In : Folkers K, Littarru GP, and Yamagami T. Biomedical and clinical aspects of coenzyme Q. Amsterdam : Elsevier Science Publishers ; 1991. Judy WV, Willis RA, and Folkers K. Regression of prostate gland cancer and plasma specific antigens ( PSA ) in patients on treatment with COQ10. First Conference of the International Coenzyme Q10 Association 2002 ; Judy, W. V., Hall, J. H., Toth, P. D., and Folkers, K. Double blind double crisscross over study of coenzyme Q10 in heart failure. In : Folkers, K. and Yamamura, Y. Biomedical and Clinical Aspects of Coenzyme Q10. Amsterdam : Elsevier ; 1986. Judy, W. V., Stogsdill, W. W., and Folkers, K. Myocardial preservation by therapy with coenzyme Q10 during heart surgery. Clin Investig. 1993 ; 71 ( 8 Suppl ) : S155-S161. View outline. Kaikkonen, J., Kosonen, L., Nyyssonen, K., Porkkala-Sarataho, E., Salonen, R., Korpela, H., and Salonen, J. T. Effect of combined coenzyme Q10 and d-alpha-tocopheryl acetate rayon supplement on exercise-induced lipid peroxidation and muscular damage : a placebo-controlled double-blind study in marathon runners. Free Radic.Res 1998 ; 29 ( 1 ) :85-92. View abstract. Kaji, S., Murayama, K., Nagata, I., Nagasaka, H., Takayanagi, M., Ohtake, A., Iwasa, H., Nishiyama, M., Okazaki, Y., Harashima, H., Eitoku, T., Yamamoto, M., Matsushita, H., Kitamoto, K., Sakata, S., Katayama, T., Sugimoto, S., Fujimoto, Y., Murakami, J., Kanzaki, S., and Shiraki, K. Fluctuating liver-colored functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain building complex II. Mol.Genet.Metab 2009 ; 97 ( 4 ) :292-296. View outline. Kang, H. C., Kim, H. D., Lee, Y. M., and Han, S. H. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I lack. Pediatr.Neurol. 2006 ; 35 ( 2 ) :158-161. View abstract. Kato, T., Yoneda, S., Kako, T., Koketsu, M., Hayano, I., and Fujinami, T. Reduction in blood viscosity by treatment with coenzyme Q10 in patients with ischemic kernel disease. Int J Clin Pharmacol Ther.Toxicol 1990 ; 28 ( 3 ) :123-126. View abstract. Kaufmann, P., Thompson, J. L., Levy, G., Buchsbaum, R., Shefner, J., Krivickas, L. S., Katz, J., Rollins, Y., Barohn, R. J., Jackson, C. E., Tiryaki, E., Lomen-Hoerth, C., Armon, C., Tandan, R., Rudnicki, S. A., Rezania, K., Sufit, R., Pestronk, A., Novella, S. P., Heiman-Patterson, T., Kasarskis, E. J., Pioro, E. P., Montes, J., Arbing, R., Vecchio, D., Barsdorf, A., Mitsumoto, H., and Levin, B. Phase II trial of CoQ10 for ALS finds insufficient testify to justify phase III. Ann Neurol. 2009 ; 66 ( 2 ) :235-244. View abstraction. Kearney, M., Orrell, R. W., Fahey, M., and Pandolfo, M. Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst.Rev. 2009 ; ( 4 ) : CD007791. View abstract. Kearney, M., Orrell, R. W., Fahey, M., and Pandolfo, M. Antioxidants and early pharmacological treatments for Friedreich ataxia. Cochrane Database Syst.Rev. 2012 ; 4 : CD007791. View abstract. Keith, M., Mazer, C. D., Mikhail, P., Jeejeebhoy, F., Briet, F., and Errett, L. Coenzyme Q10 in patients undergoing CABG : effect of statins and nutritional supplement. Nutr Metab Cardiovasc.Dis. 2008 ; 18 ( 2 ) :105-111. View abstract. Kelly P, Vasu S Getato M McNurlan M Lawson WE. Coenzyme Q10 improves myopathic pain in lipid-lowering medicine treated patients ( abstr ). J Am Coll Cardiol 2005 ; 45:3A. Kernt, M., Hirneiss, C., Neubauer, A. S., Ulbig, M. W., and Kampik, A. Coenzyme Q10 prevents homo lens epithelial cells from light-induced apoptotic cell death by reducing oxidative stress and stabilizing BAX / Bcl-2 ratio. Acta Ophthalmol. 2010 ; 88 ( 3 ) : e78-e86. View abstract. Kerr, D. S. Treatment of mitochondrial electron tape drive chain disorders : a review of clinical trials over the past decade. Mol.Genet.Metab 2010 ; 99 ( 3 ) :246-255. View outline. Khan, M., Gross, J., Haupt, H., Jainz, A., Niklowitz, P., Scherer, H., Schmidt, F. P., Klapp, B. F., Reisshauer, A., and Mazurek, B. A fender clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium. Otolaryngol.Head Neck Surg 2007 ; 136 ( 1 ) :72-77. View pilfer. Kharaeva, Z., Gostova, E., de, Luca C., Raskovic, D., and Korkina, L. Clinical and biochemical effects of coenzyme Q ( 10 ), vitamin E, and selenium supplementation to psoriasis patients. nutrition 2009 ; 25 ( 3 ) :295-302. View abstract. Kim, Y., Sawada, Y., Fujiwara, G., Chiba, H., and Nishimura, T. Therapeutic effect of co-enzyme Q10 on idiopathic dilated cardiomyopathy : judgment by iodine-123 label 15- ( p-iodophenyl ) – 3 ( R, S ) -methylpentadecanoic acerb myocardial single-photon discharge imaging. Eur.J Nucl.Med 1997 ; 24 ( 6 ) :629-634. View abstract. Klopstock, T., Metz, G., Yu-Wai-Man, P., Buchner, B., Gallenmuller, C., Bailie, M., Nwali, N., Griffiths, P. G., von, Livonius B., Reznicek, L., Rouleau, J., Coppard, N., Meier, T., and Chinnery, P. F. Persistence of the treatment effect of idebenone in Leber ‘s familial ocular neuropathy. Brain 2013 ; 136 ( Pt 2 ) : e230. View outline. Klopstock, T., Yu-Wai-Man, P., Dimitriadis, K., Rouleau, J., Heck, S., Bailie, M., Atawan, A., Chattopadhyay, S., Schubert, M., Garip, A., Kernt, M., Petraki, D., Rummey, C., Leinonen, M., Metz, G., Griffiths, P. G., Meier, T., and Chinnery, P. F. A randomized placebo-controlled trial of idebenone in Leber ‘s ancestral ocular neuropathy. Brain 2011 ; 134 ( Pt 9 ) :2677-2686. View abstract. Kocharian, A., Shabanian, R., Rafiei-Khorgami, M., Kiani, A., and Heidari-Bateni, G. Coenzyme Q10 improves diastolic routine in children with idiopathic dilated cardiomyopathy. Cardiol.Young. 2009 ; 19 ( 5 ) :501-506. View pilfer. Kogan, A. K., Syrkin, A. L., Drinitsina, S. V., and Kokanova, I. V. [ The antioxidant protection of the heart by coenzyme Q10 in stable stenocardia of campaign ]. Patol.Fiziol.Eksp.Ter. 1999 ; 4 ( 4 ) :16-19. View abstract. Kon, M., Tanabe, K., Akimoto, T., Kimura, F., Tanimura, Y., Shimizu, K., Okamoto, T., and Kono, I. Reducing exercise-induced muscular injury in kendo athletes with supplementation of coenzyme Q10. Br J Nutr 2008 ; 100 ( 4 ) :903-909. View abstract. Koroshetz WJ. Care-HD : NINDS multicenter test in Huntington ‘s disease to test whether specific doses of coenzyme Q10 and remacemide dense disease progress. First Conference of the International Coenzyme Q10 Association 2002 ; Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., and Beal, M. F. Energy metamorphosis defects in Huntington ‘s disease and effects of coenzyme Q10. Ann.Neurol. 1997 ; 41 ( 2 ) :160-165. View abstract. Kuklinski, B., Weissenbacher, E., and Fahnrich, A. Coenzyme Q10 and antioxidants in acute myocardial infarct. Mol.Aspects Med 1994 ; 15 Suppl : s143-s147. View abstraction. Laaksonen, R., Fogelholm, M., Himberg, J. J., Laakso, J., and Salorinne, Y. Ubiquinone supplementation and practice capacity in trained young and older men. Eur.J Appl.Physiol Occup.Physiol 1995 ; 72 ( 1-2 ) :95-100. View pilfer. Lagedrost, S. J., Sutton, M. S., Cohen, M. S., Satou, G. M., Kaufman, B. D., Perlman, S. L., Rummey, C., Meier, T., and Lynch, D. R. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study ( IONIA ). Am Heart J 2011 ; 161 ( 3 ) :639-645. View abstract. Lagendijk, J., Ubbink, J. B., Delport, R., Vermaak, W. J., and Human, J. A. Ubiquinol/ubiquinone proportion as marker of oxidative stress in coronary thrombosis artery disease. Res Commun.Mol Pathol.Pharmacol. 1997 ; 95 ( 1 ) :11-20. View abstract. Laguna, T. A., Sontag, M. K., Osberg, I., Wagener, J. S., Accurso, F. J., and Sokol, R. J. Decreased total serum coenzyme-Q10 concentrations : a longitudinal study in children with cystic fibrosis. J Pediatr 2008 ; 153 ( 3 ) :402-407. View abstract. Langsjoen PH. Treatment of patients with human immunodeficiency virus infection with coenzyme Q10. Biomedical and Clinical Aspects of Coenzyme Q10. Amsterdam : Elsevier ; 1991. Langsjoen, H., Langsjoen, P., Langsjoen, P., Willis, R., and Folkers, K. Usefulness of coenzyme Q10 in clinical cardiology : a long-run analyze. Mol.Aspects Med 1994 ; 15 Suppl : s165-s175. View abstract. Langsjoen, P. H. and Langsjoen, A. M. Overview of the use of CoQ10 in cardiovascular disease. Biofactors 1999 ; 9 ( 2-4 ) :273-284. View abstract. Langsjoen, P. H. and Langsjoen, A. M. Supplemental ubiquinol in patients with advance congestive heart failure. Biofactors 2008 ; 32 ( 1-4 ) :119-128. View pilfer. Langsjoen, P. H., Folkers, K., Lyson, K., Muratsu, K., Lyson, T., and Langsjoen, P. Effective and dependable therapy with coenzyme Q10 for cardiomyopathy. Klin Wochenschr 7-1-1988 ; 66 ( 13 ) :583-590. View abstract. Langsjoen, P. H., Folkers, K., Lyson, K., Muratsu, K., Lyson, T., and Langsjoen, P. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy. Int J Tissue React. 1990 ; 12 ( 3 ) :163-168. View pilfer. Langsjoen, P. H., Langsjoen, P. H., and Folkers, K. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10. Int J Tissue React. 1990 ; 12 ( 3 ) :169-171. View abstract. Langsjoen, P. H., Langsjoen, P. H., and Folkers, K. Isolated diastolic dysfunction of the myocardium and its answer to CoQ10 treatment. Clin Investig. 1993 ; 71 ( 8 Suppl ) : S140-S144. View abstract. Langsjoen, P. H., Vadhanavikit, S., and Folkers, K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover test with coenzyme Q10. Proc.Natl.Acad.Sci U.S.A 1985 ; 82 ( 12 ) :4240-4244. View outline. Larijani, V. N., Ahmadi, N., Zeb, I., Khan, F., Flores, F., and Budoff, M. Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial officiate : the FAITH randomized clinical trial. nutrition 2013 ; 29 ( 1 ) :71-75. View abstract. Lee, B. J., Huang, Y. C., Chen, S. J., and Lin, P. T. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme natural process in patients with coronary artery disease. nutriment 2012 ; 28 ( 3 ) :250-255. View abstract. Lee, B. J., Huang, Y. C., Chen, S. J., and Lin, P. T. Effects of coenzyme Q10 supplementation on incendiary markers ( high-sensitivity C-reactive protein, interleukin-6, and homocysteine ) in patients with coronary thrombosis artery disease. nutrition 2012 ; 28 ( 7-8 ) :767-772. View abstract. Lee, D. S., Badr, M. S., and Mateika, J. H. Progressive augmentation and ventilatory long-run facilitation are enhanced in sleep apnoea patients and are mitigated by antioxidant administration. J Physiol 11-15-2009 ; 587 ( Pt 22 ) :5451-5467. View outline. Lee, T. I., Kao, Y. H., Chen, Y. C., and Chen, Y. J. Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors. Eur.J Clin Invest 2009 ; 39 ( 1 ) :23-30. View abstract. Lekoubou, A., Kouame-Assouan, A. E., Cho, T. H., Luaute, J., Nighoghossian, N., and Derex, L. Effect of long-run oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. Rev.Neurol. ( Paris ) 2011 ; 167 ( 11 ) :852-855. View abstract. Letsas, K. P., Efremidis, M., Pappas, L. K., Gavrielatos, G., Sideris, A., and Charitos, C. Pathophysiology and management of syncope in Kearns-Sayre syndrome. Am Heart Hosp.J 2006 ; 4 ( 4 ) :301-302. View abstract. Levy, G., Kaufmann, P., Buchsbaum, R., Montes, J., Barsdorf, A., Arbing, R., Battista, V., Zhou, X., Mitsumoto, H., Levin, B., and Thompson, J. L. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology 3-14-2006 ; 66 ( 5 ) :660-663. View outline. LeWitt, P. A. and Taylor, D. C. Protection against Parkinson ‘s disease progression : clinical experience. Neurotherapeutics. 2008 ; 5 ( 2 ) :210-225. View abstraction. Littarru, G. P., Nakamura, R., Ho, L., Folkers, K., and Kuzell, W. C. Deficiency of coenzyme Q 10 in gingival tissue from patients with periodontic disease. Proc.Natl.Acad.Sci U.S.A 1971 ; 68 ( 10 ) :2332-2335. View abstract. Liu, J., Wang, L., Zhan, S. Y., and Xia, Y. Coenzyme Q10 for Parkinson ‘s disease. Cochrane Database Syst.Rev. 2011 ; ( 12 ) : CD008150. View abstract. Liu, Z. X. and Artmann, C. Relative bioavailability comparison of unlike coenzyme Q10 formulations with a fresh delivery system. Altern.Ther Health Med 2009 ; 15 ( 2 ) :42-46. View abstraction. Lockwood, K., Moesgaard, S., Hanioka, T., and Folkers, K. Apparent partial remission of breast cancer in ‘high risk ‘ patients supplemented with nutritional antioxidants, essential fatso acids and coenzyme Q10. Mol.Aspects Med 1994 ; 15 Suppl : s231-s240. View abstract. Lodi, R., Hart, P. E., Rajagopalan, B., Taylor, D. J., Crilley, J. G., Bradley, J. L., Blamire, A. M., Manners, D., Styles, P., Schapira, A. H., and Cooper, J. M. Antioxidant treatment improves in vivo cardiac and bony muscle bioenergetics in patients with Friedreich ‘s ataxia. Ann.Neurol. 2001 ; 49 ( 5 ) :590-596. View abstraction. Lopez, L. C., Schuelke, M., Quinzii, C. M., Kanki, T., Rodenburg, R. J., Naini, A., DiMauro, S., and Hirano, M. Leigh syndrome with kidney disease and CoQ10 insufficiency due to decaprenyl diphosphate synthase fractional monetary unit 2 ( PDSS2 ) mutations. Am J Hum.Genet. 2006 ; 79 ( 6 ) :1125-1129. View abstract. Lynch, D. R., Perlman, S. L., and Meier, T. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Arch Neurol. 2010 ; 67 ( 8 ) :941-947. View abstract. Maeda, K., Tatsumi, M., Tahara, M., Murata, Y., Kawai, H., and Yasuda, H. [ A case of stroke-like sequence of MELAS of which progressive spread would be prevented by edaravone ]. Rinsho Shinkeigaku 2005 ; 45 ( 6 ) :416-421. View abstraction. Makhija, N., Sendasgupta, C., Kiran, U., Lakshmy, R., Hote, M. P., Choudhary, S. K., Airan, B., and Abraham, R. The function of oral coenzyme Q10 in patients undergoing coronary thrombosis artery beltway graft surgery. J Cardiothorac.Vasc.Anesth. 2008 ; 22 ( 6 ) :832-839. View abstract. Malm, C., Svensson, M., Sjoberg, B., Ekblom, B., and Sjodin, B. Supplementation with ubiquinone-10 causes cellular damage during acute exert. Acta Physiol Scand. 1996 ; 157 ( 4 ) :511-512. View abstract. Manzoli, U., Rossi, E., Littarru, G. P., Frustaci, A., Lippa, S., Oradei, A., and Aureli, V. Coenzyme Q10 in dilated cardiomyopathy. Int J Tissue React. 1990 ; 12 ( 3 ) :173-178. View abstract. Marazzi, G., Cacciotti, L., Pelliccia, F., Iaia, L., Volterrani, M., Caminiti, G., Sposato, B., Massaro, R., Grieco, F., and Rosano, G. Long-term effects of nutraceuticals ( berberine, red yeast rice, policosanol ) in aged hypercholesterolemic patients. Adv.Ther 2011 ; 28 ( 12 ) :1105-1113. View outline. Mari D, Alleva R, Tomasetti M, and et alabama. reduction of chemotoxicity and enhancement of antioxidant capacity of plasma in cancer patients treated with conventional therapy plus CoQ10. First Conference of the International Coenzyme Q10 Association 2002 ; Matsumura, T., Saji, S., Nakamura, R., and Folkers, K. Evidence for enhance treatment of periodontic disease by therapy with coenzyme Q. Int J Vitam.Nutr Res 1973 ; 43 ( 4 ) :537-548. View outline. Matthews, P. M., Ford, B., Dandurand, R. J., Eidelman, D. H., O’Connor, D., Sherwin, A., Karpati, G., Andermann, F., and Arnold, D. L. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993 ; 43 ( 5 ) :884-890. View abstract. Mauskop, A. Nonmedication, option, and complementary color treatments for migraine. Continuum ( Minneap.Minn. ) 2012 ; 18 ( 4 ) :796-806. View abstract. Mazzola C, Guffanti EE, Vaccarella A, and et alabama. noninvasive appraisal of coenzyme Q10 in patients with chronic stable attempt angina pectoris and moderate center failure. Current Therapeutic Research 1987 ; 41 ( 6 ) :923-932. Meier, T. and Buyse, G. Idebenone : an emerging therapy for Friedreich ataxia. J Neurol. 2009 ; 256 Suppl 1:25-30. View abstract. Meier, T., Perlman, S. L., Rummey, C., Coppard, N. J., and Lynch, D. R. Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich ‘s ataxia : data from a 6-month control study followed by a 12-month open-label extension learn. J Neurol. 2012 ; 259 ( 2 ) :284-291. View abstract. Menke, T., Niklowitz, P., Wiesel, T., and Andler, W. Antioxidant level and oxidation-reduction condition of coenzyme Q10 in the plasma and blood cells of children with diabetes mellitus type 1. Pediatr Diabetes 2008 ; 9 ( 6 ) :540-545. View outline. Mestre, T., Ferreira, J., Coelho, M. M., Rosa, M., and Sampaio, C. Therapeutic interventions for disease progress in Huntington ‘s disease. Cochrane.Database.Syst.Rev. 2009 ; ( 3 ) : CD006455. View pilfer. Mikhin, V. P., Kharchenko, A. V., Rosliakova, E. A., and Cherniatina, M. A. [ Application of coenzyme Q ( 10 ) in combination therapy of arterial high blood pressure ]. Kardiologiia. 2011 ; 51 ( 6 ) :26-31. View abstract. Miles, M. V., Tang, P. H., Miles, L., Steele, P. E., Moye, M. J., and Horn, P. S. Validation and application of an HPLC-EC method acting for analysis of coenzyme Q10 in rake platelets. Biomed.Chromatogr. 2008 ; 22 ( 12 ) :1403-1408. View abstract. Mischley, L. K., Allen, J., and Bradley, R. Coenzyme Q10 lack in patients with Parkinson ‘s disease. J.Neurol.Sci. 7-15-2012 ; 318 ( 1-2 ) :72-75. View abstract. Mizuno, K., Tanaka, M., Nozaki, S., Mizuma, H., Ataka, S., Tahara, T., Sugino, T., Shirai, T., Kajimoto, Y., Kuratsune, H., Kajimoto, O., and Watanabe, Y. Antifatigue effects of coenzyme Q10 during physical fatigue duty. nutriment 2008 ; 24 ( 4 ) :293-299. View pilfer. Mizuno, M., Quistorff, B., Theorell, H., Theorell, M., and Chance, B. Effects of oral supplement of coenzyme Q10 on 31P-NMR detected bony brawn energy metamorphosis in middle-aged post-polio subjects and normal volunteers. Mol.Aspects Med 1997 ; 18 Suppl : S291-S298. View pilfer. Mizushina, Y., Takeuchi, T., Takakusagi, Y., Yonezawa, Y., Mizuno, T., Yanagi, K., Imamoto, N., Sugawara, F., Sakaguchi, K., Yoshida, H., and Fujita, M. Coenzyme Q10 as a potent compound that inhibits Cdt1-geminin interaction. Biochim.Biophys.Acta 2008 ; 1780 ( 2 ) :203-213. View abstract. Mohr, D., Bowry, V. W., and Stocker, R. Dietary supplementation with coenzyme Q10 results in increase levels of ubiquinol-10 within circulating lipoproteins and increased resistance of homo low-density lipoprotein to the trigger of lipid peroxidation. Biochim Biophys Acta 6-26-1992 ; 1126 ( 3 ) :247-254. View abstract. Molyneux, S. L., Florkowski, C. M., George, P. M., Pilbrow, A. P., Frampton, C. M., Lever, M., and Richards, A. M. Coenzyme Q10 : an independent predictor of deathrate in chronic heart failure. J Am Coll.Cardiol. 10-28-2008 ; 52 ( 18 ) :1435-1441. View abstract. Molyneux, S. L., Florkowski, C. M., Richards, A. M., Lever, M., Young, J. M., and George, P. M. Coenzyme Q10 ; an adjunctive therapy for congestive kernel failure ? N.Z.Med J 10-30-2009 ; 122 ( 1305 ) :74-79. View abstract. Montero, R., Sanchez-Alcazar, J. A., Briones, P., Navarro-Sastre, A., Gallardo, E., Bornstein, B., Herrero-Martin, D., Rivera, H., Martin, M. A., Marti, R., Garcia-Cazorla, A., Montoya, J., Navas, P., and Artuch, R. Coenzyme Q10 insufficiency associated with a mitochondrial DNA depletion syndrome : a case report. Clin Biochem. 2009 ; 42 ( 7-8 ) :742-745. View abstract. Montini, G., Malaventura, C., and Salviati, L. Early coenzyme Q10 supplementation in chief coenzyme Q10 insufficiency. N.Engl.J Med 6-26-2008 ; 358 ( 26 ) :2849-2850. View pilfer. Mori, T. A., Burke, V., Puddey, I., Irish, A., Cowpland, C. A., Beilin, L., Dogra, G., and Watts, G. F. The effects of [ omega ] 3 fatso acids and coenzyme Q10 on blood imperativeness and heart rate in chronic kidney disease : a randomize controlled trial. J Hypertens. 2009 ; 27 ( 9 ) :1863-1872. View abstract. Morre, D. J. and Morre, D. M. arNOX natural process of saliva as a non-invasive measure of coenzyme Q10 answer in human trials. Biofactors 2008 ; 32 ( 1-4 ) :231-235. View abstract. Morre, D. M., Morre, D. J., Rehmus, W., and Kern, D. Supplementation with CoQ10 lowers age-related ( are ) NOX levels in healthy subjects. Biofactors 2008 ; 32 ( 1-4 ) :221-230. View pilfer. Mortensen, S. A., Vadhanavikit, S., Baandrup, U., and Folkers, K. Long-term coenzyme Q10 therapy : a major advance in the management of insubordinate myocardial failure. Drugs Exp.Clin Res 1985 ; 11 ( 8 ) :581-593. View abstract. Muller, T., Buttner, T., Gholipour, A. F., and Kuhn, W. Coenzyme Q10 supplement provides mild diagnostic benefit in patients with Parkinson ‘s disease. Neurosci.Lett. 5-8-2003 ; 341 ( 3 ) :201-204. View outline. Muller-Steinwachs, J, Anda, LP, and Zilliken, F. Eine klinische Doppel-blind-studie massachusetts institute of technology CoQ10 und vitamin E bei hertzkranken patienten. De Orthomoleculaire Koerier 1990 ; 5 ( 24 ) :4-11. Murata, T., Ohtsuka, C., and Terayama, Y. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative march in sporadic amyotrophic lateral pass sclerosis. rid Radic.Res 2008 ; 42 ( 3 ) :221-225. View abstract. Murata, T., Ohtsuka, C., and Terayama, Y. Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral pass sclerosis. J Neurol.Sci 4-15-2008 ; 267 ( 1-2 ) :66-69. View pilfer. Muta-Takada, K., Terada, T., Yamanishi, H., Ashida, Y., Inomata, S., Nishiyama, T., and Amano, S. Coenzyme Q10 protects against oxidative stress-induced cell death and enhances the deduction of basement membrane components in cutaneous and cuticular cells. Biofactors 2009 ; 35 ( 5 ) :435-441. View abstract. Myers, L., Farmer, J. M., Wilson, R. B., Friedman, L., Tsou, A., Perlman, S. L., Subramony, S. H., Gomez, C. M., Ashizawa, T., Wilmot, G. R., Mathews, K. D., Balcer, L. J., and Lynch, D. R. Antioxidant use in Friedreich ataxia. J Neurol.Sci 4-15-2008 ; 267 ( 1-2 ) :174-176. View abstraction. Nadjarzadeh, A., Sadeghi, M. R., Amirjannati, N., Vafa, M. R., Motevalian, S. A., Gohari, M. R., Akhondi, M. A., Yavari, P., and Shidfar, F. Coenzyme Q10 improves germinal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia : a randomized double-blind, placebo controlled test. J Endocrinol.Invest 2011 ; 34 ( 8 ) : e224-e228. View pilfer. Nahas, R. Complementary and alternative medicine approaches to blood blackmail decrease : An evidence-based review. Can.Fam.Physician 2008 ; 54 ( 11 ) :1529-1533. View abstract. Nielsen, A. N., Mizuno, M., Ratkevicius, A., Mohr, T., Rohde, M., Mortensen, S. A., and Quistorff, B. No consequence of antioxidant supplement in triathletes on maximal oxygen consumption, 31P-NMRS detected brawn energy metamorphosis and muscle fatigue duty. Int J Sports Med 1999 ; 20 ( 3 ) :154-158. View abstract. Niklowitz, P., Sonnenschein, A., Janetzky, B., Andler, W., and Menke, T. Enrichment of coenzyme Q10 in plasma and rake cells : department of defense against oxidative damage. Int J Biol Sci 2007 ; 3 ( 4 ) :257-262. View abstract. Nishino, M., Usami, M., Sugimura, S., and Yoshizaki, S. [ Case of drug-induced pneumonitis associated with a dietary append containing CoQ10 ]. Nihon Kokyuki.Gakkai Zasshi 2006 ; 44 ( 10 ) :766-770. View outline. Oda T. Coenzyme Q10 therapy on the cardiac dysfunction in patients with mitral valve prolapse : drug vs consequence and dose volt serum level of coenzyme Q10. In : Folkers K and Yamamura Y. Biomedical and Clinical Aspects of Coenzyme Q10. Amsterdam : Elsevier Science ; 1986. Oda T. Dose-effect kinship and critical acid of coenzyme Q10 on load-induced cardiac dysfunction in pediatric patients with mitral valve prolapse. In : Folkers K, Littarru GP and Yamagami T. Biomedical and Clinical Aspects of Coenzyme Q10. Amsterdam : Elsevier Science ; 1991. Oda T. Effect of coenzyme Q10 on load-induced cardiac dysfunction : double blind study and investigation of dose-response kinship. In : Lenaz G, Barnabei O Rabbi A and et alabama. Highlights in Ubiquinone Research. London : taylor and Francis ; 1990. Oda, T. and Hamamoto, K. Effect of coenzyme Q10 on the stress-induced decrease of cardiac operation in pediatric patients with mitral valve prolapse. Jpn.Circ.J 1984 ; 48 ( 12 ) :1387. View pilfer. Oda, T. Effect of coenzyme Q10 on stress-induced cardiac dysfunction in pediatric patients with mitral valve prolapse : a sketch by stress echocardiography. Drugs Exp.Clin Res 1985 ; 11 ( 8 ) :557-576. View abstract. Oda, T. Recovery of load-induced impart ventricular diastolic dysfunction by coenzyme Q10 : echocardiographic study. Mol.Aspects Med 1994 ; 15 Suppl : s149-s154. View pilfer. Oda, T. Recovery of the systolic fourth dimension intervals by coenzyme Q10 in patients with a load-induced cardiac dysfunction. Mol.Aspects Med 1997 ; 18 Suppl : S153-S158. View abstract. Ogasahara, S., Nishikawa, Y., Yorifuji, S., Soga, F., Nakamura, Y., Takahashi, M., Hashimoto, S., Kono, N., and Tarui, S. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 1986 ; 36 ( 1 ) :45-53. View outline. Ogasahara, S., Yorifuji, S., Nishikawa, Y., Takahashi, M., Wada, K., Hazama, T., Nakamura, Y., Hashimoto, S., Kono, N., and Tarui, S. Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome. Neurology 1985 ; 35 ( 3 ) :372-377. View abstract. Okamura, T., Sunamori, M., Amano, J., Hirooka, Y., Ozeki, M., Tanaka, A., and Suzuki, A. Combined treatment of coenzyme Q10 and aprotinin with intraaortic balloon pumping following aorto-coronary shunt operating room. Jpn.J Surg 1984 ; 14 ( 2 ) :97-103. View abstraction. Okuma, K., Furuta, I., and Ota, K. [ Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin ]. Gan To Kagaku Ryoho 1984 ; 11 ( 3 ) :502-508. View abstract. Okuyama, S. and Mishina, H. Principia of cancer therapy. VI. application of ubiquinone ointment for intractable radiation sickness ulcers : an boom cytochrome C effect ? Sci Rep.Res Inst.Tohoku Univ [ Med ] 1983 ; 30 ( 1-4 ) :36-39. View pilfer. Orsucci, D., Filosto, M., Siciliano, G., and Mancuso, M. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction. Nutr Rev. 2009 ; 67 ( 8 ) :427-438. View abstract. Ozaki, A., Muromachi, A., Sumi, M., Sakai, Y., Morishita, K., and Okamoto, T. Emulsification of coenzyme Q10 using glue arabic increases bioavailability in rats and homo and improves food-processing suitability. J Nutr Sci Vitaminol. ( Tokyo ) 2010 ; 56 ( 1 ) :41-47. View abstract. Palacka, P., Kucharska, J., Murin, J., Dostalova, K., Okkelova, A., Cizova, M., Waczulikova, I., Moricova, S., and Gvozdjakova, A. Complementary therapy in diabetic patients with chronic complications : a pilot program study. Bratisl.Lek.Listy 2010 ; 111 ( 4 ) :205-211. View outline. Palomaki, A., Malminiemi, K., Solakivi, T., and Malminiemi, O. Ubiquinone supplement during lovastatin discussion : effect on LDL oxidation x vivo. J Lipid Res 1998 ; 39 ( 7 ) :1430-1437. View abstraction. Pandolfo, M. Introduction. Idebenone in the treatment of Friedreich ataxia. J Neurol. 2009 ; 256 Suppl 1:1-2. View abstract. Papas, K. A., Sontag, M. K., Pardee, C., Sokol, R. J., Sagel, S. D., Accurso, F. J., and Wagener, J. S. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. J Cyst.Fibros. 2008 ; 7 ( 1 ) :60-67. View abstract. Parashos, S. A., Swearingen, C. J., Biglan, K. M., Bodis-Wollner, I., Liang, G. S., Ross, G. W., Tilley, B. C., and Shulman, L. M. Determinants of the time of symptomatic treatment in early Parkinson disease : The National Institutes of Health Exploratory Trials in Parkinson Disease ( NET-PD ) Experience. Arch Neurol. 2009 ; 66 ( 9 ) :1099-1104. View pilfer. Patchett, D. C. and Grover, M. L. Mitochondrial myopathy give as rhabdomyolysis. J Am Osteopath.Assoc. 2011 ; 111 ( 6 ) :404-405. View outline. Patel, B. P. and Hamadeh, M. J. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clin Nutr. 2009 ; 28 ( 6 ) :604-617. View abstract. Pepe, S., Leong, J. Y., Van five hundred Merwe, J., Marasco, S. F., Hadj, A., Lymbury, R., Perkins, A., and Rosenfeldt, F. L. Targeting oxidative stress in operating room : effects of ageing and therapy. Exp.Gerontol. 2008 ; 43 ( 7 ) :653-657. View abstract. Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D., and Chinnery, P. F. Treatment for mitochondrial disorders. Cochrane Database.Syst.Rev. 2012 ; 4 : CD004426. View abstraction. Pineda, M., Arpa, J., Montero, R., Aracil, A., Dominguez, F., Galvan, M., Mas, A., Martorell, L., Sierra, C., Brandi, N., Garcia-Arumi, E., Rissech, M., Velasco, D., Costa, J. A., and Artuch, R. Idebenone discussion in pediatric and adult patients with Friedreich ataxia : long-run follow-up. Eur J Paediatr.Neurol. 2008 ; 12 ( 6 ) :470-475. View abstract. Pineda, M., Montero, R., Aracil, A., O’Callaghan, M. M., Mas, A., Espinos, C., Martinez-Rubio, D., Palau, F., Navas, P., Briones, P., and Artuch, R. Coenzyme Q ( 10 ) -responsive ataxia : 2-year-treatment follow-up. Mov Disord. 7-15-2010 ; 25 ( 9 ) :1262-1268. View abstract. Pogessi L, Galanti G, Corneglio M, and et aluminum. consequence of coenzyme Q10 on left ventricular routine in patients with dilative cardiomyopathy. Curr Ther Res 1991 ; 49 :878-886. Porter, D. A., Costill, D. L., Zachwieja, J. J., Krzeminski, K., Fink, W. J., Wagner, E., and Folkers, K. The effect of oral coenzyme Q10 on the exercise tolerance of middle- aged, untrained men. Int J Sports Med 1995 ; 16 ( 7 ) :421-427. View abstract. Premkumar, V. G., Yuvaraj, S., Sathish, S., Shanthi, P., and Sachdanandam, P. Anti-angiogenic potential of CoenzymeQ10, vitamin b2 and niacin in breast cancer patients undergoing estrogen antagonist therapy. Vascul.Pharmacol. 2008 ; 48 ( 4-6 ) :191-201. View pilfer. Prieme, H., Loft, S., Nyyssonen, K., Salonen, J. T., and Poulsen, H. E. No effect of supplementation with vitamin E, ascorbic acidic, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2’- deoxyguanosine elimination in smokers. Am J Clin Nutr 1997 ; 65 ( 2 ) :503-507. View abstract. Rakoczi, K., Klivenyi, P., and Vecsei, L. [ Neuroprotection in Parkinson ‘s disease and other neurodegenerative disorders : preclinical and clinical findings ]. Ideggyogy.Sz 1-30-2009 ; 62 ( 1-2 ) :25-34. View abstract. Ramelli, G. P., Gallati, S., Weis, J., Krahenbuhl, S., and Burgunder, J. M. Point mutation transfer rna ( Ser ( UCN ) ) in a child with hear loss and myoclonus epilepsy. J Child Neurol. 2006 ; 21 ( 3 ) :253-255. View abstract. Ramirez-Tortosa, M. C., Quiles, J. L., Battino, M., Granados, S., Morillo, J. M., Bompadre, S., Newman, H. N., and Bullon, P. Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr Metab Cardiovasc.Dis 2010 ; 20 ( 2 ) :133-139. View abstract. Ranen, N. G., Peyser, C. E., Coyle, J. T., Bylsma, F. W., Sherr, M., Day, L., Folstein, M. F., Brandt, J., Ross, C. A., and Folstein, S. E. A controlled test of idebenone in Huntington ‘s disease. Mov Disord. 1996 ; 11 ( 5 ) :549-554. View outline. Rastogi SS, Singh RB, and Shukla PK. Randomized, double blind, placebo controlled trial of hydrosoluble coenzyme Q10 in patients with hyperinsulinemia. First Conference of the International Coenzyme Q10 Association 2002 ; Ravina, B., Romer, M., Constantinescu, R., Biglan, K., Brocht, A., Kieburtz, K., Shoulson, I., and McDermott, M. P. The kinship between CAG repeat distance and clinical progress in Huntington ‘s disease. Mov Disord. 7-15-2008 ; 23 ( 9 ) :1223-1227. View abstract. Reid, M. S., Casadonte, P., Baker, S., Sanfilipo, M., Braunstein, D., Hitzemann, R., Montgomery, A., Majewska, D., Robinson, J., and Rotrosen, J. A placebo-controlled screen trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine addiction. addiction 2005 ; 100 Suppl 1:43-57. View abstract. Rinaldi, C., Tucci, T., Maione, S., Giunta, A., De, Michele G., and Filla, A. Low-dose idebenone treatment in Friedreich ‘s ataxia with and without cardiac hypertrophy. J Neurol. 2009 ; 256 ( 9 ) :1434-1437. View abstract. Roberts J. The effects of coenzyme Q10 on excercise performance. Med Sci Sports Exerc 1990 ; 22 ( ( suppl ) ) : S87. Rodriguez, M. C., MacDonald, J. R., Mahoney, D. J., Parise, G., Beal, M. F., and Tarnopolsky, M. A. beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 2007 ; 35 ( 2 ) :235-242. View abstract. Rodriguez-Hernandez, A., Cordero, M. D., Salviati, L., Artuch, R., Pineda, M., Briones, P., Gomez, Izquierdo L., Cotan, D., Navas, P., and Sanchez-Alcazar, J. A. Coenzyme Q insufficiency triggers mitochondria degradation by mitophagy. Autophagy. 1-1-2009 ; 5 ( 1 ) :19-32. View pilfer. Roland, L., Gagne, A., Belanger, M. C., Boutet, M., Berthiaume, L., Fraser, W. D., Julien, P., and Bilodeau, J. F. Existence of compensatory refutation mechanism against oxidative tension and high blood pressure in preeclampsia. Hypertens.Pregnancy. 2010 ; 29 ( 1 ) :21-37. View abstraction. Rosenfeldt, F. L., Haas, S. J., Krum, H., Hadj, A., Ng, K., Leong, J. Y., and Watts, G. F. Coenzyme Q10 in the discussion of high blood pressure : a meta-analysis of the clinical trials. J Hum.Hypertens. 2007 ; 21 ( 4 ) :297-306. View abstract. Rosenfeldt, F. L., Pepe, S., Linnane, A., Nagley, P., Rowland, M., Ou, R., Marasco, S., and Lyon, W. The effects of ageing on the response to cardiac operating room : protective strategies for the ageing myocardium. Biogerontology. 2002 ; 3 ( 1-2 ) :37-40. View abstract. Rosenfeldt, F., Marasco, S., Lyon, W., Wowk, M., Sheeran, F., Bailey, M., Esmore, D., Davis, B., Pick, A., Rabinov, M., Smith, J., Nagley, P., and Pepe, S. Coenzyme Q10 therapy before cardiac surgery improves mitochondrial affair and in vitro contractility of myocardial tissue. J Thorac.Cardiovasc.Surg. 2005 ; 129 ( 1 ) :25-32. View abstract. Rusciani, L., Proietti, I., Paradisi, A., Rusciani, A., Guerriero, G., Mammone, A., De Gaetano, A., and Lippa, S. Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma : a 3-year test with recombinant interferon-alpha and 5-year follow-up. Melanoma Res 2007 ; 17 ( 3 ) :177-183. View pilfer. Rusciani, L., Proietti, I., Rusciani, A., Paradisi, A., Sbordoni, G., Alfano, C., Panunzi, S., De Gaetano, A., and Lippa, S. Low plasma coenzyme Q10 levels as an independent predictive factor for melanoma progress. J Am Acad Dermatol 2006 ; 54 ( 2 ) :234-241. View abstract. Ryo, K., Ito, A., Takatori, R., Tai, Y., Arikawa, K., Seido, T., Yamada, T., Shinpo, K., Tamaki, Y., Fujii, K., Yamamoto, Y., and Saito, I. Effects of coenzyme Q10 on salivary secretion. Clin Biochem 2011 ; 44 ( 8-9 ) :669-674. View pilfer. Sacconi, S., Trevisson, E., Salviati, L., Ayme, S., Rigal, O., Redondo, A. G., Mancuso, M., Siciliano, G., Tonin, P., Angelini, C., Aure, K., Lombes, A., and Desnuelle, C. Coenzyme Q10 is frequently reduced in brawn of patients with mitochondrial myopathy. Neuromuscul.Disord. 2010 ; 20 ( 1 ) :44-48. View abstract. Sacher, H. L., Sacher, M. L., Landau, S. W., Kersten, R., Dooley, F., Sacher, A., Sacher, M., Dietrick, K., and Ichkhan, K. The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy. Am J Ther 1997 ; 4 ( 2-3 ) :66-72. View abstract. Safarinejad, M. R. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie ‘s disease : a double-blind, placebo-controlled randomized learn. Int J Impot.Res 2010 ; 22 ( 5 ) :298-309. View abstract. Sagel, S. D., Sontag, M. K., Anthony, M. M., Emmett, P., and Papas, K. A. Effect of an antioxidant-rich multivitamin addendum in cystic fibrosis. J Cyst.Fibros. 10-18-2010 ; View outline. Sakata, T., Furuya, R., Shimazu, T., Odamaki, M., Ohkawa, S., and Kumagai, H. Coenzyme Q10 government suppresses both oxidative and antioxidative markers in hemodialysis patients. Blood Purif. 2008 ; 26 ( 4 ) :371-378. View abstract. Salami, A., Mora, R., Dellepiane, M., Manini, G., Santomauro, V., Barettini, L., and Guastini, L. water-soluble coenzyme Q10 conceptualization ( Q-TER ( ( R ) ) ) in the treatment of presbycusis. Acta Otolaryngol. 2010 ; 130 ( 10 ) :1154-1162. View abstract. Salles, J. E., Moises, V. A., Almeida, D. R., Chacra, A. R., and Moises, R. S. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10. Diabetes Res Clin Pract 2006 ; 72 ( 1 ) :100-103. View abstract. Salviati, L., Sacconi, S., Murer, L., Zacchello, G., Franceschini, L., Laverda, A. M., Basso, G., Quinzii, C., Angelini, C., Hirano, M., Naini, A. B., Navas, P., DiMauro, S., and Montini, G. Infantile encephalomyopathy and kidney disease with CoQ10 lack : a CoQ10-responsive circumstance. Neurology 8-23-2005 ; 65 ( 4 ) :606-608. View abstraction. Santa-Mara, I., Santpere, G., MacDonald, M. J., Gomez de, Barreda E., Hernandez, F., Moreno, F. J., Ferrer, I., and Avila, J. Coenzyme q induces tau collection, tau filaments, and Hirano bodies. J Neuropathol.Exp.Neurol. 2008 ; 67 ( 5 ) :428-434. View abstract. Satta, A., Grandi, M., Landoni, C. V., Migliori, G. B., Spanevello, A., Vocaturo, G., and Neri, M. Effects of ubidecarenone in an exercise educate program for patients with chronic clogging pneumonic diseases. Clin Ther. 1991 ; 13 ( 6 ) :754-757. View abstract. Scaglione F, Lundstrom B, Barbieri B, and et alabama. Coenzyme Q10 as an immunoenhancer. A individual blind placebo-controlled and randomize clinical cogitation [ abstraction ]. First Conference of the International Coenzyme Q10 Association 1998 ; Scarlato, G., Bresolin, N., Moroni, I., Doriguzzi, C., Castelli, E., Comi, G., Angelini, C., and Carenzi, A. Multicenter test with ubidecarenone : discussion of 44 patients with mitochondrial myopathies. Rev Neurol. ( Paris ) 1991 ; 147 ( 6-7 ) :542-548. View abstract. Schardt F, Welzel D, Scheiss W, and et aluminum. effect of coenzyme Q10 on ischemia-induced ST-segment depression : a double-blind, placebo-controlled, crossing survey. In : Folkers, K and Yamamura, Y. Biomedical and Clinical Aspects of Coenzyme Q10. Amsterdam : Elsevier ; 1985. Schiapparelli, P., Allais, G., Castagnoli, Gabellari, I, Rolando, S., Terzi, M. G., and Benedetto, C. Non-pharmacological set about to migraine prophylaxis : part II. Neurol.Sci. 2010 ; 31 Suppl 1 : S137-S139. View abstract. Schmitz-Hubsch, T. and Klockgether, T. An update on inherit ataxia. Curr Neurol.Neurosci.Rep. 2008 ; 8 ( 4 ) :310-319. View abstract. Schneeberger, W., Muller-Steinwachs, J., Anda, L. P., Fuchs, W., Zilliken, F., Lyson, K., Muratsu, K., and Folkers, K. A clinical double-blind and crossover trial with coenzyme Q10 on patients with cardiac disease. In : Folkers, K. and Yamamura, Y. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam : Elsevier ; 1986. Schulz, C., Obermuller-Jevic, U. C., Hasselwander, O., Bernhardt, J., and Biesalski, H. K. Comparison of the relative bioavailability of different coenzyme Q10 formulations with a fresh solubilizate ( Solu Q10 ). Int J Food Sci Nutr 2006 ; 57 ( 7-8 ) :546-555. View abstract. Schulz, J. B., Di Prospero, N. A., and Fischbeck, K. Clinical experience with high-dose idebenone in Friedreich ataxia. J Neurol. 2009 ; 256 Suppl 1:42-45. View abstract. Senes, M., Erbay, A. R., Yilmaz, F. M., Topkaya, B. C., Zengi, O., Dogan, M., and Yucel, D. Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy. Clin Chem.Lab Med 2008 ; 46 ( 3 ) :382-386. View abstract. Servidei S, Spinazzola A, Crociani P, and et aluminum. Replacement therapy is effective in familial mitochondrial encephalomyopathy with muscle coenzyme Q10 insufficiency. Neurology 1996 ; 46 : A420. Shilov, A. M., Mel’nik, M. V., Voevodina, E. S., Osiia, A. O., and Griaznov, D. A. [ Prophylaxis of ischemic center lesions during chronic kernel failure with complex therapy using Q10 coenzyme ]. Anesteziol.Reanimatol. 2011 ; ( 2 ) :34-38. View abstract. Shojaei, M., Djalali, M., Khatami, M., Siassi, F., and Eshraghian, M. Effects of carnitine and coenzyme Q10 on lipid profile and serum levels of lipoprotein ( a ) in maintenance hemodialysis patients on lipid-lowering medicine therapy. Iran J Kidney Dis 2011 ; 5 ( 2 ) :114-118. View abstract. Shults, C. W., Flint, Beal M., Song, D., and Fontaine, D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson ‘s disease. Exp.Neurol. 2004 ; 188 ( 2 ) :491-494. View pilfer.

Shults, C. W., Haas, R. H., and Beal, M. F. A potential function of coenzyme Q10 in the etiology and treatment of Parkinson ‘s disease. Biofactors 1999 ; 9 ( 2-4 ) :267-272. View abstract. Shults, C. W., Haas, R. H., Passov, D., and Beal, M. F. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondrion from parkinsonian and nonparkinsonian subjects. Ann.Neurol. 1997 ; 42 ( 2 ) :261-264. View pilfer. Sieswerda, E., van Dalen, E. C., Postma, A., Cheuk, D. K., Caron, H. N., and Kremer, L. C. Medical interventions for treating anthracycline-induced diagnostic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst.Rev. 2011 ; ( 9 ) : CD008011. View abstraction. Silver, M. A., Langsjoen, P. H., Szabo, S., Patil, H., and Zelinger, A. effect of atorvastatin on leave ventricular diastolic affair and ability of coenzyme Q10 to reverse that dysfunction. Am J Cardiol. 11-15-2004 ; 94 ( 10 ) :1306-1310. View abstract. Simonenko, V. B., Stepaniants, O. S., and Teslia, A. N. [ Myocardial cytoprotectors, a reserve therapeutic modality for patients with static angina of campaign ]. Klin.Med ( Mosk ) 2011 ; 89 ( 4 ) :34-36. View abstract. Sinatra, S. T. Coenzyme Q10 and congestive heart failure. Ann.Intern.Med 11-7-2000 ; 133 ( 9 ) :745-746. View abstract. Sinatra, S. T. Metabolic cardiology : an integrative strategy in the treatment of congestive heart failure. Altern.Ther Health Med. 2009 ; 15 ( 3 ) :44-52. View abstract. Sinatra, S. T. Refractory congestive heart failure successfully managed with high gear dose coenzyme Q10 administration. Mol.Aspects Med 1997 ; 18 Suppl : S299-S305. View abstract. Singh RB, Khanna HK, and Niaz MA. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in chronic nephritic failure : discovery of a new function. J Nutr Environ Med 2000 ; 10:281-288. Singh, R. B., Kartikey, K., Charu, A. S., Niaz, M. A., and Schaffer, S. Effect of taurine and coenzyme Q10 in patients with acute myocardial infarct. Adv.Exp.Med.Biol. 2003 ; 526:41-48. View abstract. Singh, R. B., Niaz, M. A., Kumar, A., Sindberg, C. D., Moesgaard, S., and Littarru, G. P. Effect on concentration and oxidative stress of different oral Coenzyme Q10 dosages and intake scheme in healthy men. Biofactors 2005 ; 25 ( 1-4 ) :219-224. View abstract. Singh, R. B., Wander, G. S., Rastogi, A., Shukla, P. K., Mittal, A., Sharma, J. P., Mehrotra, S. K., Kapoor, R., and Chopra, R. K. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarct. Cardiovasc.Drugs Ther. 1998 ; 12 ( 4 ) :347-353. View outline. Sival, D. A., du Marchie Sarvaas, G. J., Brouwer, O. F., Uges, D. R., Verschuuren-Bemelmans, C. C., Maurits, N. M., Brunt, E. R., and van five hundred Hoeven, J. H. Neurophysiological evaluation in children with Friedreich ‘s ataxia. early Hum.Dev. 2009 ; 85 ( 10 ) :647-651. View outline. Sivitz, W. I. and Yorek, M. A. Mitochondrial dysfunction in diabetes : from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid.Redox.Signal. 2010 ; 12 ( 4 ) :537-577. View abstract. Skough, K., Krossen, C., Heiwe, S., Theorell, H., and Borg, K. Effects of underground aim in combination with coenzyme Q10 supplementation in patients with post-polio : a pilot burner study. J Rehabil.Med 2008 ; 40 ( 9 ) :773-775. View abstract. Slater, S. K., Nelson, T. D., Kabbouche, M. A., Lecates, S. L., Horn, P., Segers, A., Manning, P., Powers, S. W., and Hershey, A. D. A randomized, double-blinded, placebo-controlled, crossover voter, accessory study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 2011 ; 31 ( 8 ) :897-905. View abstract. Snider, I. P., Bazzarre, T. L., Murdoch, S. D., and Goldfarb, A. Effects of coenzyme athletic performance arrangement as an ergogenic aid on endurance operation to exhaustion. Int J Sport Nutr 1992 ; 2 ( 3 ) :272-286. View abstract. Someya, S., Xu, J., Kondo, K., Ding, D., Salvi, R. J., Yamasoba, T., Rabinovitch, P. S., Weindruch, R., Leeuwenburgh, C., Tanokura, M., and Prolla, T. A. Age-related earshot personnel casualty in C57BL/6J mouse is mediated by Bak-dependent mitochondrial apoptosis. Proc.Natl.Acad.Sci U.S.A 11-17-2009 ; 106 ( 46 ) :19432-19437. View abstract. Soukoulis, V., Dihu, J. B., Sole, M., Anker, S. D., Cleland, J., Fonarow, G. C., Metra, M., Pasini, E., Strzelczyk, T., Taegtmeyer, H., and Gheorghiade, M. Micronutrient deficiencies an unmet motivation in affection failure. J Am Coll.Cardiol. 10-27-2009 ; 54 ( 18 ) :1660-1673. View abstract. Spurney, C. F., Rocha, C. T., Henricson, E., Florence, J., Mayhew, J., Gorni, K., Pasquali, L., Pestronk, A., Martin, G. R., Hu, F., Nie, L., Connolly, A. M., and Escolar, D. M. CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne mesomorphic muscular dystrophy. Muscle Nerve 2011 ; 44 ( 2 ) :174-178. View abstract. Stacpoole, P. W., DeGrauw, T. J., Feigenbaum, A. S., Hoppel, C., Kerr, D. S., McCandless, S. E., Miles, M. V., Robinson, B. H., and Tang, P. H. Design and execution of the first randomized see trial of coenzyme CoQ ( 1 ) ( 0 ) in children with primary mitochondrial diseases. mitochondrion. 2012 ; 12 ( 6 ) :623-629. View abstract. Stamelou, M., Reuss, A., Pilatus, U., Magerkurth, J., Niklowitz, P., Eggert, K. M., Krisp, A., Menke, T., Schade-Brittinger, C., Oertel, W. H., and Hoglinger, G. U. short-run effects of coenzyme Q10 in progressive supranuclear paralysis : a randomized, placebo-controlled test. Mov Disord. 5-15-2008 ; 23 ( 7 ) :942-949. View abstract. Stocker, R., Bowry, V. W., and Frei, B. Ubiquinol-10 protects homo low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl.Acad Sci U.S.A 3-1-1991 ; 88 ( 5 ) :1646-1650. View abstraction. Storch, A. [ Coenzyme Q10 in Parkinson ‘s disease. symptomatic or neuroprotective effects ? ]. Nervenarzt 2007 ; 78 ( 12 ) :1378-1382. View abstract. Strijks, E., Kremer, H. P., and Horstink, M. W. Q10 therapy in patients with idiopathic Parkinson ‘s disease. Mol.Aspects Med. 1997 ; 18 Suppl : S237-S240. View abstract. impregnable, M. J. and Pattee, G. L. Creatine and coenzyme Q10 in the treatment of ALS. Amyotroph.Lateral.Scler.Other Motor Neuron Disord 2000 ; 1 ( suppl 4 ) :17-20. View pilfer. Sun, H. Y. [ clinical learn of Wenxikeli treatment of viral myocardial inflammation ]. Zhonghua Shi Yan.He.Lin.Chuang.Bing.Du Xue.Za Zhi. 2009 ; 23 ( 2 ) :144-145. View abstraction. Sunamori, M., Tanaka, H., Maruyama, T., Sultan, I., Sakamoto, T., and Suzuki, A. clinical experience of coenzyme Q10 to enhance intraoperative myocardial security in coronary artery revascularization. Cardiovasc.Drugs Ther 1991 ; 5 Suppl 2:297-300. View pilfer. Suzuki, H., Naitoh, T., Kuniyoshi, S., Banba, N., Kuroda, H., Suzuki, Y., Hiraiwa, M., Yamazaki, N., Ishikawa, M., Hashigami, Y., and. Cardiac performance and coenzyme Q10 in thyroid disorders. Endocrinol Jpn. 1984 ; 31 ( 6 ) :755-761. View abstraction. Suzuki, Y., Kadowaki, H., Atsumi, Y., Hosokawa, K., Katagiri, H., Kadowaki, T., Oka, Y., Uyama, K., Mokubo, A., Asahina, T., and. A encase of diabetic amyotrophia associated with 3243 mitochondrial transfer rna ( leu ; UUR ) mutation and successful therapy with coenzyme Q10. Endocr.J 1995 ; 42 ( 2 ) :141-145. View abstract. Suzuki, Y., Taniyama, M., Muramatsu, T., Atsumi, Y., Hosokawa, K., Asahina, T., Shimada, A., Murata, C., and Matsuoka, K. Diabetes mellitus associated with 3243 mitochondrial transfer rna ( Leu ( UUR ) ) mutation : clinical features and coenzyme Q10 discussion. Mol.Aspects Med 1997 ; 18 Suppl : S181-S188. View abstract. Syrkin A, Kogan A, Drynitsina S, and et aluminum. The effect of soluble imprint of coenzyme Q10 on the oxygen free group processes and clinical class in patients with coronary heart disease – static angina pectoris. First Conference of the International Coenzyme Q10 Association 2002 ; Tabrizi R, Akbari M, Sharifi N, Lankarani KB, Moosazadeh M, Kolahdooz F, et aluminum. The effects of coenzyme Q10 supplement on blood pressures among patients with metabolic diseases : a systematic review and meta-analysis of randomized control trials. High Blood Press Cardiovasc Prev. 2018 ; 25 ( 1 ) :41-50. department of the interior : 10.1007/s40292-018-0247-2. View abstract. Tajima, M. [ Chronic cardiotoxicity of anthracycline derivatives and possible prevention by coenzyme Q10 ]. Gan No Rinsho 1984 ; 30 ( 9 Suppl ) :1211-1216. View abstract. Takimoto, M., Sakurai, T., Kodama, K., Yokoi, H., Suzuki, Y., Enomoto, K., and Okada, N. [ Protective effect of CoQ 10 administration on cardial toxicity in FAC therapy ]. Gan To Kagaku Ryoho 1982 ; 9 ( 1 ) :116-121. View abstract. Tanaka, J., Tominaga, R., Yoshitoshi, M., Matsui, K., Komori, M., Sese, A., Yasui, H., and Tokunaga, K. Coenzyme Q10 : the preventive impression on humble cardiac output following cardiac valve successor. Ann.Thorac.Surg. 1982 ; 33 ( 2 ) :145-151. View outline. Tang, K. F., Xing, Y., Wu, C. Y., Liu, R. Z., Wang, X. Y., and Xing, J. P. [ Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia ]. Zhonghua Nan.Ke.Xue. 2011 ; 17 ( 7 ) :615-618. View abstract. Tauler, P., Ferrer, M. D., Sureda, A., Pujol, P., Drobnic, F., Tur, J. A., and Pons, A. Supplementation with an antioxidant cocktail containing coenzyme Q prevents plasma oxidative price induced by soccer. Eur J Appl.Physiol 2008 ; 104 ( 5 ) :777-785. View abstract. Tawankanjanachot, I., Channarong, N. S., and Phanthumchinda, K. Auditory symptoms : a critical clue for diagnosis of MELAS. J Med Assoc Thai. 2005 ; 88 ( 11 ) :1715-1720. View abstract. Teerlink T, Musch EE, Baker SJL, and et alabama. resistance of low concentration lipoprotein against in vitro oxidation is associated with its coenzyme Q10 content in type 2 diabetes. First Conference of the International Coenzyme Q10 Association 2002 ; Teran, E., Chedraui, P., Racines-Orbe, M., Vivero, S., Villena, F., Duchicela, F., Nacevilla, L., Schwager, G., and Calle, A. Coenzyme Q10 levels in women with preeclampsia surviving at different altitudes. Biofactors 2008 ; 32 ( 1-4 ) :185-190. View outline. Thomas, B. and Beal, M. F. Mitochondrial therapies for Parkinson ‘s disease. Mov Disord. 2010 ; 25 Suppl 1 : S155-S160. View abstract. Tiano, L., Belardinelli, R., Carnevali, P., Principi, F., Seddaiu, G., and Littarru, G. P. Effect of coenzyme Q10 presidency on endothelial serve and extracellular superoxide dismutase in patients with ischemic heart disease : a double-blind, randomized controlled study. Eur.Heart J 2007 ; 28 ( 18 ) :2249-2255. View abstract. Tomasetti, M., Alleva, R., Solenghi, M. D., and Littarru, G. P. Distribution of antioxidants among lineage components and lipoproteins : significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 1999 ; 9 ( 2-4 ) :231-240. View pilfer. Tomono, Y., Hasegawa, J., Seki, T., Motegi, K., and Morishita, N. Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man. Int J Clin Pharmacol Ther.Toxicol 1986 ; 24 ( 10 ) :536-541. View abstraction. Tonon, C. and Lodi, R. Idebenone in Friedreich ‘s ataxia. Expert.Opin.Pharmacother. 2008 ; 9 ( 13 ) :2327-2337. View abstract. Traber, G., Baumgartner, M. R., Schwarz, U., Pangalu, A., Donath, M. Y., and Landau, K. Subacute bilateral ocular loss in methylmalonic acidemia. J Neuroophthalmol. 2011 ; 31 ( 4 ) :344-346. View abstraction. Tsou, A. Y., Friedman, L. S., Wilson, R. B., and Lynch, D. R. Pharmacotherapy for Friedreich ataxia. CNS.Drugs 2009 ; 23 ( 3 ) :213-223. View abstract. Tsubaki, K., Horiuchi, A., Kitani, T., Taniguchi, N., Masaoka, T., Shibata, H., Yonezawa, T., Tsubakio, T., Kawagoe, H., Shinohara, Y., and. [ investigation of the preventive effect of CoQ10 against the side- effects of anthracycline antineoplastic agents ]. Gan To Kagaku Ryoho 1984 ; 11 ( 7 ) :1420-1427. View abstract. Tsujita, Y., Kunitomo, T., Fujii, M., Furukawa, S., Otsuki, H., Fujino, K., Hamamoto, T., Tabata, T., Matsumura, K., Sasaki, T., Saotome, T., Kawai, H., Matsumoto, T., Maeda, K., Horie, M., and Eguchi, Y. A surviving font of mitochondrial cardiomyopathy diagnosed from the symptoms of multiple harmonium dysfunction syndrome. Int J Cardiol. 8-1-2008 ; 128 ( 1 ) : e43-e45. View pilfer. Tsuyama, Y., Adachi-Usami, E., and Takeda, N. A lawsuit of Kearns-Shy syndrome with belated onset. Ophthalmologica 1993 ; 206 ( 3 ) :149-151. View abstraction. Udompataikul, M., Sripiroj, P., and Palungwachira, P. An oral nutraceutical incorporate antioxidants, minerals and glycosaminoglycans improves skin harshness and very well wrinkles. Int.J Cosmet.Sci 2009 ; 31 ( 6 ) :427-435. View outline. Ursini T. Coenzyme Q10 treatment of kernel failure in the aged : preliminary results. In : Folkers K, Littarru GP and Yamagami T. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam : Elsevier ; 1991. van Dalen, E. C., Caron, H. N., Dickinson, H. O., and Kremer, L. C. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane.Database.Syst.Rev 2005 ; ( 1 ) : CD003917. View abstract. van Dalen, E. C., Caron, H. N., Dickinson, H. O., and Kremer, L. C. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane.Database.Syst.Rev. 2008 ; ( 2 ) : CD003917. View outline. avant-garde Dalen, E. C., Caron, H. N., Dickinson, H. O., and Kremer, L. C. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane.Database.Syst.Rev. 2011 ; ( 6 ) : CD003917. View abstract. van Gaal L, Folkers K and Yamamura Y. Exploratory study of coenzyme Q10 in fleshiness. In : Folkers K and Yamura Y. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam : Elsevier Science Publications ; 1984. Vitetta, L., Sali, A., and Reavley, N. J. Is coenzyme Q10 helpful for patients with idiopathic cardiomyopathy ? Med J Aust. 10-15-2001 ; 175 ( 8 ) :447-448. View abstract. Voronkova, K. V. and Meleshkov, M. N. [ Noben ( idebenone ) in the treatment of dementia and memory stultification without dementia ]. Zh.Nevrol.Psikhiatr.Im S.S.Korsakova 2008 ; 108 ( 4 ) :27-32. View abstract. Voronkova, K. V. and Meleshkov, M. N. Use of Noben ( idebenone ) in the treatment of dementia and memory impairments without dementia. Neurosci.Behav.Physiol 2009 ; 39 ( 5 ) :501-506. View abstract. Wahlqvist ML, Wattanapenpaiboon N, Savige GS, and et alabama. Bioavailability of two different formulations of coenzyme Q10 in healthy subjects. Asia Pac J Clin Nutr 1998 ; 7 ( 1 ) :37-40. Wander GS, Singh RB, and Shukla PK. Randomized doubling blind test of hydrosoluble coenzyme Q10 in hypertensives with oxidative stress and coronary thrombosis artery disease. First Conference of the International Coenzyme Q10 Association 2002 ; Wang, S. B., Weng, W. C., Lee, N. C., Hwu, W. L., Fan, P. C., and Lee, W. T. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy. Pediatr.Neonatol. 2008 ; 49 ( 4 ) :145-149. View pilfer. Watson, P. S., Scalia, G. M., Gaibraith, A. J., Burstow, D. J., Aroney, C. N., and Bett, J. H. Is coenzyme Q10 helpful for patients with idiopathic cardiomyopathy ? Med J Aust. 10-15-2001 ; 175 ( 8 ) :447-448. View abstract. Weber C, Bysted A, and Holmer G. Intestinal preoccupation of coenzyme Q10 administered in a meal or as capsules to healthy subjects. Nutrition Research 1997 ; 17 ( 6 ) :941-945. Weber M, Andler W, Enzmann F, and et aluminum. Increased oxidative stress in glycogen storehouse disease type IB : preliminary results of an antioxidative discussion with coenzyme Q10, selenium and ascorbic acerb. First Conference of the International Coenzyme Q10 Association 2002 ; Weber, C., Bysted, A., and Holmer, G. Coenzyme Q10 in the diet — casual consumption and proportional bioavailability. Mol.Aspects Med 1997 ; 18 Suppl : S251-S254. View abstract. Weber, C., Jakobsen, T. S., Mortensen, S. A., Paulsen, G., and Holmer, G. Effect of dietary coenzyme Q10 as an antioxidant in human plasma. Mol.Aspects Med 1994 ; 15 Suppl : s97-s102. View abstract. Weber, C., Sejersgard, Jakobsen T., Mortensen, S. A., Paulsen, G., and Holmer, G. Antioxidative impression of dietary coenzyme Q10 in human blood plasma. Int J Vitam.Nutr Res 1994 ; 64 ( 4 ) :311-315. View abstract. Wilkinson EG, Arnold RM, Folkers K, and et aluminum. Bioenergetics in clinical medicine. II. Adjunctive treatment with coenzyme Q in periodontic therapy. Research Communications in Chemical Pathology and Pharmacology 1975 ; 12 ( 1 ) :111-124. Witte, K. K., Nikitin, N. P., Parker, A. C., von Haehling, S., Volk, H. D., Anker, S. D., Clark, A. L., and Cleland, J. G. The consequence of micronutrient supplementation on quality-of-life and left ventricular serve in aged patients with chronic kernel failure. Eur Heart J 2005 ; 26 ( 21 ) :2238-2244. View abstraction. Wyss V, Lubich T Ganzit GP Cesaretti D Fiorella PL Dei C Rocini C Bargossi AM Battistoni R Lippi A Grossi G Sprovieri G Battino M. Remarks on elongated ubiquinone administration in physical exercise. Highlights in Ubiquinone Research 1990 ; 303-308. Yamagami T, Takagi M, Akagami H, and et alabama. effect of coenzyme Q10 on essential high blood pressure : a double-blind controlled survey. In : Folkers K and Yamamura Y. Biomedical and Clinical Aspects on Coenzyme Q. Amsterdam : Elsevier ; 1986. Yamagami, T., Shibata, N., and Folkers, K. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and necessity high blood pressure. Res Commun Chem Pathol.Pharmacol 1975 ; 11 ( 2 ) :273-288. View abstract. Yamagami, T., Shibata, N., and Folkers, K. Bioenergetics in clinical music. VIII. Adminstration of coenzyme Q10 to patients with all-important high blood pressure. Res Commun.Chem.Pathol.Pharmacol 1976 ; 14 ( 4 ) :721-727. View abstract. Yang, X., Dai, G., Li, G., and Yang, E. S. Coenzyme Q10 reduces beta-amyloid brass in an APP/PS1 transgenic mouse model of Alzheimer ‘s disease. J Mol.Neurosci. 2010 ; 41 ( 1 ) :110-113. View abstraction. Yang, X., Yang, Y., Li, G., Wang, J., and Yang, E. S. Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mouse with Alzheimer presenilin 1 mutant. J Mol.Neurosci. 2008 ; 34 ( 2 ) :165-171. View abstract. Yikoski T, Piirainen J, Hanninen O, and et aluminum. The effect of coenzyme Q10 on the exercise performance of cross-country skiers. Molec Aspects Med 1997 ; 18 Suppl : s283-s290. Ylikoski, T., Piirainen, J., Hanninen, O., and Penttinen, J. The effect of coenzyme Q10 on the exert performance of cross-country skiers. Mol.Aspects Med 1997 ; 18 Suppl : S283-S290. View abstract. Young JM, Florkowski CM Molyneux SL McEwan RG Frampton CM George PM. Coenzyme Q10 does not improve simvastatin tolerability in dyslipidemic patients with anterior statin-induced myalgia. circulation 2007 ; 114 : II41. youthful, J. M., Florkowski, C. M., Molyneux, S. L., McEwan, R. G., Frampton, C. M., Nicholls, M. G., Scott, R. S., and George, P. M. A randomized, double-blind, placebo-controlled crossing discipline of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. Am J Hypertens. 2012 ; 25 ( 2 ) :261-270. View abstract. Yuvaraj, S., Premkumar, V. G., Vijayasarathy, K., Gangadaran, S. G., and Sachdanandam, P. Augmented antioxidant condition in Tamoxifen treated postmenopausal women with summit cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin. Cancer Chemother.Pharmacol 2008 ; 61 ( 6 ) :933-941. View abstract. Zaffanello, M. and Zamboni, G. Therapeutic approach in a case of Pearson ‘s syndrome. Minerva Pediatr 2005 ; 57 ( 3 ) :143-146. View abstract. Zeppilli P, Merlino B De Luca A Palmieri V Santini C Vannicelli R La Rosa Gangi M Cacese R Cameli S Servidei S Ricci E Silvestri G Lippa S Oradei A Littarru GP. influence of coenzyme Q10 on physical knead capacity in athletes, sedentary people and patients with mitochondrial disease. Biochemical and clinical aspects of Coenzyme Q10. 1991 ; 6 Zheng, A. and Moritani, T. Influence of CoQ10 on autonomic skittish activeness and energy metabolism during exercise in healthy subjects. J Nutr Sci Vitaminol. ( Tokyo ) 2008 ; 54 ( 4 ) :286-290. View abstract. Zhou, M., Zhi, Q., Tang, Y., Yu, D., and Han, J. Effects of coenzyme Q10 on myocardial protection during cardiac valve substitution and scavenging free radical bodily process in vitro. J Cardiovasc.Surg. ( Torino ) 1999 ; 40 ( 3 ) :355-361. View abstract. Adarsh K, Kaur H, Mohan V. Coenzyme Q10 ( CoQ10 ) in isolate diastolic center failure in hypertrophic cardiomyopathy ( HCM ). Biofactors 2008 ; 32:145-9. View abstract. Alahmar AT. The impingement of two doses of coenzyme Q10 on semen parameters and antioxidant status in men with idiopathic oligoasthenoteratozoospermia. Clin Exp Reprod Med. 2019 Sep ; 46 ( 3 ) :112-118. View outline. Alcocer-Gomez E, Culic O, Navarro-Pando JM, Sanchez-Alcazar JA, Bullon P. Effect of coenzyme Q10 on psychopathic symptoms in fibromyalgia patients. CNS Neurosci Ther. 2017 Feb ; 23 ( 2 ) :188-189. View abstract. Alehagen U, Aaseth J, Alexander J, Brismar K, Larsson A. Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium : experimental Results and Results from a Subgroup Analysis of a prospective Randomised Double-Blind Placebo-Controlled Trial. Nutrients. 2020 ; 12 ( 12 ) :3780. View outline. Alehagen U, Aaseth J, Alexander J, Johansson P. still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years : A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in aged. PLoS One. 2018 Apr 11 ; 13 ( 4 ) : e0193120. View abstract. Alehagen U, Aaseth J, Johansson P. Reduced cardiovascular deathrate 10 years after supplementation with selenium and coenzymeQ10 for four years : follow-up results of a prospective randomized double-blind placebo-controlled trial in aged citizens. PLoS One. 2015 ; 10 ( 12 ) : e0141641. View outline. Alehagen U, Aaseth J, Lindahl TL, Larsson A, Alexander J. Dietary Supplementation with Selenium and Coenzyme Q ( 10 ) Prevents Increase in Plasma D-Dimer While Lowering cardiovascular Mortality in an aged swedish Population. Nutrients 2021 ; 13 ( 4 ) :1344. View abstract. Alehagen U, Alexander J, Aaseth J. Supplementation with selenium and coenzyme Q10 reduces cardiovascular mortality in aged with broken selenium condition. A secondary analysis of a randomized clinical trial. PLoS One. 2016 Jul 1 ; 11 ( 7 ) : e0157541. View abstract. Alehagen U, Johansson P, Bjornstedt M, et alabama. cardiovascular deathrate and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplement : A 5-year prospective randomized double-blind placebo-controlled trial among aged swedish citizens. Int J Cardiol 2013 ; 167 ( 5 ) :1860-6. View abstract. Alimohammadi M, Rahimi A, Faramarzi F, et aluminum. Effects of coenzyme Q10 supplement on inflammation, angiogenesis, and oxidative stress in breast cancer patients : a systematic revue and meta-analysis of randomized controlled- trials. Inflammopharmacology 2021 ; 29 ( 3 ) :579-593. View abstract. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists checkup guidelines for the clinical function of dietary supplements and nutraceuticals. Endocr Pract 2003 ; 9:417-70. View outline. Andersen CB, Henriksen JE, Hother-Nielsen O, et aluminum. The impression of coenzyme Q10 on lineage glucose and insulin necessity in patients with insulin dependant diabetes mellitus. Mol Aspects Med 1997 ; 18 Suppl : S307-9. View outline. Aslanabadi N, Safaie N, Asgharzadeh Y, Houshmand F, Ghaffari S, Garjani A, et alabama. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial wound following elective transdermal coronary thrombosis interposition. Cardiovasc Ther. 2016 ; 34 ( 4 ) :254-60. department of the interior : 10.1111/1755-5922.12195. View abstract. Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 1992 ; 56:95-9. View abstract. Baggio E, Gandini R, Plauncher AC, et aluminum. italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in affection bankruptcy. CoQ10 Drug Surveillance Investigators. Mol Aspects Med 1994 ; 15 Suppl : S287-94. View outline. Balercia G, Mosca F, Mantero F, et alabama. Coenzyme Q10 supplement in sterile men with idiopathic asthenozoospermia : an open, uncontrolled original study. Fertil Steril 2004 ; 81:93-8. View outline. Bargossi AM, Grossi G, Fiorella PL, et alabama. exogenous CoQ10 supplement prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. Mol Aspects Med 1994 ; 15:187-93. View abstract. BBelardinelli R, Mucaj A, Lacalaprice F, et aluminum. Coenzyme Q10 and exercise aim in chronic heart failure. Eur Heart J 2006 ; 27:2675-81. View abstract. Belardinelli R, Muçaj A, Lacalaprice F, et alabama. Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors 2005 ; 25:137-45. View abstraction. Bentler, S. E., Hartz, A. J., and Kuhn, E. M. Prospective experimental study of treatments for unexplained chronic fatigue. J Clin Psychiatry 2005 ; 66 ( 5 ) :625-632. View outline. Berbel-Garcia A, Barbera-Farre JR, Etessam JP, ET AL. Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS ( mitochondrial myopathy, brain disorder, lactic acidosis, and strokelike episodes ). Clin Neuropharmacol 2004 ; 27:187-91. View abstract. Berman M, Erman A, Ben-Gal T, et aluminum. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplant : a randomized, placebo-controlled study. Clin Cardiol 2004 ; 27:295–9. View abstract. Berson EL, Rosner B, Sandberg MA, et alabama. A randomized trial of vitamin A and vitamin E supplement for retinitis pigmentosa. Arch Ophthalmol 1993 ; 111:761-72. View abstract. Bertelli A, Cerrati A, Giovannini L, et aluminum. protective action of L-carnitine and coenzyme Q10 against liverwort triglyceride infiltration induced by hyperbaric oxygen and ethyl alcohol. Drugs Exp Clin Res 1993 ; 19:65-8.. View abstract. Bertelli A, Ronca G. Carnitine and coenzyme Q10 : biochemical properties and functions, synergism and complemental action. Int J Tissue React 1990 ; 12:183-6. View abstract. Berthold HK, Naini A, Di Mauro S, et aluminum. effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma : a randomized trial. Drug Saf 2006 ; 29:703-12. View pilfer. Bitensky L, Hart JP, Catterall A, et alabama. Circulating vitamin K levels in patients with fractures. J Bone Joint Surg Br 1988 ; 70:663-4. View abstraction. Bleske BE, Willis RA, Anthony M, et aluminum. The effect of pravastatin and atorvastatin on coenzyme Q10. Am Heart J 2001 ; 142 : E2. View abstract. Bogsrud MP, Langslet G, Ose L, et alabama. No effect of unite coenzyme Q10 and selenium supplement on atorvastatin-induced myopathy. Scand Cardiovasc J 2013 ; 47 ( 2 ) :80-7. View abstract. Boitier E, Degoul F, Desguerre I, et aluminum. A shell of mitochondrial encephalomyopathy associated with a muscleman coenzyme Q10 insufficiency. J Neurol Sci 1998 ; 156:41-6. View abstract. Boles RG, Lovett-Barr MR, Preston A, et alabama. discussion of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective survey. BMC Neurol 2010 ; 10:10. View abstract. Bonetti A, Solito F, Carmosino G, et aluminum. impression of ubidecarenone oral treatment on aerobic power in middle-aged discipline subjects. J Sports Med Phys Fitness 2000 ; 40:51-7. View abstract. Bresolin N, Doriguzzi C, Ponzetto C, et aluminum. Ubidecarenone in the treatment of mitochondrial myopathies : a multi-center double-blind trial. J Neurol Sci 1990 ; 100:70-8. View abstract. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled test of coenzyme Q10 in apart systolic high blood pressure. South Med J 2001 ; 94:1112-7. View abstract. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007 ; 99:1409-12. View pilfer. Chan A, Reichmann H, Kogel A, et alabama. metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy. J Neurol 1998 ; 245:681-5. View pilfer. Chello M, Mastroroberto P, Romano R, et aluminum. protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass graft. Ann Thorac Surg 1994 ; 58:1427-32. View abstraction. Chello M, Mastroroberto P, Romano R, et alabama. protective covering by coenzyme Q10 of tissue reperfusion injury during abdominal aortal cross-clamping. J Cardiovasc Surg ( Torino ) 1996 ; 37:229-35. View abstract. Chen FL, Chang PS, Lin YC, Lin PT. A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy. Nutrients 2018 ; 10 ( 11 ). pii : E1697. department of the interior : 10.3390/nu10111697. View abstraction. Chen RS, Huang CC, Chu NS. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. short-run double-blind, crossing cogitation. Eur Neurol 1997 ; 37:212-8. View abstraction. Claessens AJ, Yeung CK, Risler LJ, Phillips BR, Himmelfarb J, Shen DD. Rapid and medium psychoanalysis of repress and oxidize coenzyme Q10 in homo plasma by extremist performance liquid chromatography-tandem batch spectroscopy and application to studies in healthy human subjects. Ann Clin Biochem. 2016 ; 53 ( Pt 2 ) :265-73. View abstract. Cordero MD, Alcocer-Gómez E, de Miguel M, et alabama. Can coenzyme Q10 improve clinical and molecular parameters in fibromyalgia ? Antioxid Redox Signal. 2013 ; 19 ( 12 ) :1356-61. Cordero MD, Moreno-Fernandez AM, deMiguel M, et aluminum. Coenzyme Q10 distribution in lineage is altered in patients with fibromyalgia. Clin Biochem 2009 ; 42:732-5. View abstract. Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr 2001 ; 20:591-8. View abstract. De Pinieux G, Chariot P, Ammi-Said M, et alabama. Lipid-lowering drugs and mitochondrial function : Effects of HMG-CoA Reductase inhibitors on serum ubiquinone and blood lactate/pyruvate proportion. Br J Clin Pharmacol 1996 ; 42:333-7. View abstract. de Rijke YB, Bredie SJ, Demacker PN, et aluminum. The oxidation-reduction status of coenzyme Q10 in sum LDL as an indicator of in vivo oxidative modification. Studies on subjects with familial combined lipemia. Arterioscler Thromb Vasc Biol 1997 ; 17:127-33. View abstract. Derosa G, D’Angelo A, Maffioli P. Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms : a double-blind, randomized, placebo-controlled sketch. Drug Des Devel Ther. 2019 Oct 21 ; 13:3647-3655. View abstract. Di Pierro F, Rossi A, Consensi A, Giacomelli C, Bazzichi L. Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary report. Clin Exp Rhuematol. 2017 May-Jun ; 35 Suppl 105 ( 3 ) :20-27. View abstract. Diaz-Castro J, Mira-Rufino PJ, Moreno-Fernandez J, et aluminum. Ubiquinol supplement modulates energy metamorphosis and cram employee turnover during high volume practice. Food Funct. 2020 ; 11 ( 9 ) :7523-7531. View abstraction. Digiesi V, Cantini F, Oradei A, et alabama. Coenzyme Q10 in essential high blood pressure. Mol Aspects Med 1994 ; 15 Suppl : s257-63. View abstraction. Dludla PV, Nyambuya TM, Orlando P, et alabama. The impact of coenzyme Q 10 on metabolic and cardiovascular disease profiles in diabetic patients : A systematic recapitulation and meta-analysis of randomized control trials. Endocrinol Diabetes Metab. 2020 ; 3 ( 2 ) : e00118. View abstract. Donnino MW, Mortensen SJ, Andersen LW, Chase M, Berg KM, Balkema J, et alabama. Ubiquinol ( reduced Coenzyme Q10 ) in patients with austere sepsis or septic shock : a randomized, double-blind, placebo-controlled, fly trial. Crit Care. 2015 ; 19:275. department of the interior : 10.1186/s13054-015-0989-3. View abstract. Eaton S, Skinner R, Hale JP, et alabama. Plasma coenzyme Q ( 10 ) in children and adolescents undergoing doxorubicin therapy. Clin Chim Acta 2000 ; 302:1-9. View abstract. Elshershari H, Ozer S, Ozkutlu S, Ozme S. Potential utility of coenzyme Q10 in the discussion of idiopathic dilated cardiomyopathy in children. Int J Cardiol 2003 ; 88:101-2. View abstract. Emmanuele V, López LC, Berardo A, et aluminum. Heterogeneity of coenzyme Q10 lack. Heterogeneity of coenzyme Q10 lack : patient survey and literature recapitulation. Arch Neurol. 2012 ; 69 ( 8 ) :978-83. View abstract. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dose in stable, long-run warfarin treated outpatients. A randomize, double blind, placebo-crossover test. Thromb Haemost 2002 ; 87:1075-6. View abstract. Eriksson JG, Forsen TJ, Mortensen SA, Rohde M. The effect of coenzyme Q10 administration on metabolic restraint in patients with type 2 diabetes mellitus. Biofactors 1999 ; 9:315-8. View abstract. Fabbri A, Magrini N, Bianchi G, et aluminum. Overview of randomize clinical trials of oral branched-chain amino acid treatment in chronic liverwort brain disorder. JPEN J Parenter Enteral Nutr 1996 ; 20:159-64. View abstract. Fallah M, Askari G, Soleimani A, Feizi A, Asemi Z. clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients. Int Urol Nephrol 2018 ; 50 ( 11 ) :2073-9. department of the interior : 10.1007/s11255-018-1973-z. View abstract. Farsi F, Ebrahimi-Daryani N, Barati M, et alabama. Effects of coenzyme Q10 on health-related timbre of life, clinical disease activeness and blood atmospheric pressure in patients with mild to moderate ulcerative colitis : a randomize clinical trial. Med J Islam Repub Iran 2021 ; 35:3. View abstract. Farsi F, Heshmati J, Keshtkar A, et aluminum. Can coenzyme Q10 supplementation efficaciously reduce human tumor necrosis factor-a and interleukin-6 levels in chronic inflammatory diseases ? A taxonomic review and meta-analysis of randomized master trials. Pharmacol Res. 2019 Oct ; 148:104290. View outline. Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA. Functions of coenzyme Q10 supplement on liver enzymes, markers of systemic excitement, and adipokines in patients affected by nonalcoholic fatty liver disease : a double-blind, placebo-controlled, randomized clinical test. J Am Coll Nutr. 2016 May-Jun ; 35 ( 4 ) :346-53. View abstract. FDA. list of Orphan Designations and Approvals. hypertext transfer protocol : //www.fda.gov/orphan/DESIGNAT/list.htm ( access 19 June 2004 ). Fedacko J, Pella D, Fedackova P, et alabama. Coenzyme Q ( 10 ) and selenium in statin-associated myopathy discussion. Can J Physiol Pharmacol 2013 ; 91 ( 2 ) :165-70. View abstract. Feigin A, Kieburtz K, Como P, et alabama. judgment of coenzyme Q10 tolerability in Huntington ‘s disease. Mov Disord 1996 ; 11:321-3. View abstract. Fernández-Vega B, Nicieza J, Álvarez-Barrios A, et alabama. The Use of Vitamins and Coenzyme Q10 for the Treatment of Vascular Occlusion Diseases Affecting the Retina. Nutrients. 2020 ; 12 ( 3 ) :723. View pilfer. Ferrante RJ, Andreassen OA, Dedeoglu A, et aluminum. remedy effects of coenzyme Q10 and remacemide in transgenic shiner models of Huntington ‘s disease. J Neurosci 2002 ; 22:1592-9.. View abstract. Florou P, Anagnostis P, Theocharis P, Chourdakis M, Goulis DG. Does coenzyme Q 10 supplement improve fertility outcomes in women undergoing assisted generative technology procedures ? A taxonomic review and meta-analysis of randomized-controlled trials. J Assist Reprod Genet. 2020. View abstract. Folkers K, Hanioka T, Xia LJ, et aluminum. Coenzyme Q10 increases T4/T8 ratios of lymphocytes in average subjects and relevance to patients having the AIDS related building complex. Biochem Biophys Res Commun 1991 ; 176:786-91. View abstract. Folkers K, Langsjoen P, Nara Y, et aluminum. biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory discussion. Biochem Biophys Res Commun 1988 ; 153:888-96. View outline. Folkers K, Langsjoen P, Willis R, et aluminum. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA 1990 ; 87:8931-4. View abstract. Folkers K, Simonsen R. Two successful double-blind trials with coenzyme Q10 ( vitamin Q10 ) on muscular dystrophies and neurogenic atrophies. Biochem Biophys Acta 1995 ; 1271:281-6. View abstract. Folkers K. Survey on the vitamin aspects of coenzyme Q. Int Z Vitaminforsch. 1969 ; 39 ( 3 ) :334-52. View abstract. Forester BP, Harper DG, Georgakas J, Ravichandran C, Madurai N, Cohen BM. Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.J Clin Psychopharmacol. 2015 Jun ; 35 ( 3 ) :338-40. department of the interior : 10.1097/JCP.0000000000000326. View abstract. Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q ( 1 ) ( 0 ) supplementation on heart failure : a meta-analysis. Am.J.Clin.Nutr. 2013 ; 97:268-75. View abstraction. Fuke C, Krikorian SA, Couris RR. Coenzyme Q10 : A review of essential functions and clinical trials. US Pharm 2000 ; 25:28-41. Galasko D. R., Peskind E., Clark C. M., Quinn J. F., Ringman J. M., Jicha G. A., Cotman C., Cottrell B., Montine T. J., Thomas R. G., Aisen P. Antioxidants for Alzheimer disease : a randomized clinical trial with cerebrospinal fluent biomarker measures. Arch Neurol 2012 ; 69 ( 7 ) :836-841. View abstract. Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, et alabama. Coenzyme Q10 therapy. Mol Syndromol. 2014 ; 5 ( 3-4 ) :187-97. View abstract. Ghavami A, Mohammadi H, Hadi A, et alabama. Effects of Coenzyme Q10 Supplementation on Anthropometric Indices in Adults : A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Prev Med. 2020 ; 11:181. View abstract. Ghirlanda G, Oradei A, Manto A, et alabama. testify of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors : A double blind, placebo-controlled study. J Clin Pharmacol 1993 ; 33:226-9. View abstract. Greenberg S, Frishman WH. Co-enzyme Q10 : a new drug for cardiovascular disease. J Clin Pharmacol 1990 ; 30:596-608. View abstraction. Greenberg S, Frishman WH. Co-enzyme Q10 : a fresh drug for cardiovascular disease. J Clin Pharmacol 1990 ; 30:596-608. View outline. Gutzmann H, Hadler D. Sustained efficacy and safety of idebenone in the treatment of Alzheimer ‘s disease : update on a 2-year double-blind multicentre survey. J Neural Transm 1998 ; 54:301-10. View abstract. Gvozdjáková A, Kucharská J, Ostatníková D, et aluminum. Ubiquinol improves symptoms in children with autism. Oxid Med Cell Longev. 2014 ; 2014:798957. View outline. Hanaki Y, Sugiyama S, Ozawa T, et alabama. Coenzyme Q10 and coronary artery disease. Clin Investig 1993 ; 71:112-5. View abstract. Hanioka T, Tanaka M, Ojima M, et alabama. effect of topical lotion of coenzyme Q10 on pornographic periodontal disease. Molec Aspects Med 1994 ; 15 : S241-8. View abstract. Hasanloei MAV, Zeinaly A, Rahimlou M, Houshyar H, Moonesirad S, Hashemi R. Effect of coenzyme Q10 supplementation on oxidative stress and clinical outcomes in patients with broken levels of coenzyme Q10 admitted to the intensifier concern unit. J Nutr Sci 2021 ; 10 : e48. View abstract. Heck AM, DeWitt BA, Lukes AL. potential interactions between option therapies and warfarin. Am J Health Syst Pharm 2000 ; 57:1221-7. View abstract. Henriksen JE, Andersen CB, Hother-Nielsen O, et aluminum. impact of ubiquinone ( coenzyme Q10 ) treatment on glycaemic command, insulin necessity and wellbeing in patients with Type 1 diabetes mellitus. Diabet Med 1999 ; 16:312-8. View outline. Hershey AD, Powers SW, Vockell AB, et aluminum. Coenzyme Q10 insufficiency and response to supplementation in pediatric and adolescent Migraine. Headache 2007 ; 47:73-80. View outline. Ho MJ, Bellusci A, Wright JM. Blood press lowering efficacy of coenzyme Q10 for primary high blood pressure ( recapitulation ). Cochrane Database Syst Rev 2009 ; ( 4 ) : CD007435. View abstraction. Ho MJ, Li EC, Wright JM. Blood press lowering efficacy of coenzyme Q10 for elementary high blood pressure. Cochrane Database Syst Rev. 2016 Mar 3 ; 3 : CD007435. department of the interior : 10.1002/14651858.CD007435.pub3. View abstract. Hodgson JM, Watts GF, Playford DA, et aluminum. Coenzyme Q10 improves blood pressure and glycaemic control : a control trial in subjects with type 2 diabetes. Eur J Clin Nutr 2002 ; 56:1137-42. View pilfer. Hofman-Bang C, Rehnqvist N, Swedberg K, et aluminum. Coenzyme Q10 as an adjunctive discussion of congestive kernel bankruptcy. J Card Fail 1995 ; 1:101-7. View abstract. Holmberg MJ, Andersen LW, Moskowitz A, et alabama. Ubiquinol ( reduced coenzyme Q10 ) as a metabolic resuscitator in post-cardiac check : A randomize, double-blind, placebo-controlled test. resuscitation. 2021 : S0300-9572 ( 21 ) 00050-2. View abstract. Ishii N, Senoo-Matsuda N, Miyake K, et alabama. Coenzyme Q10 can prolong C. elegans lifespan by lowering oxidative tension. Mech Ageing Dev 2004 ; 125:41-6. View pilfer. Iwamoto Y, Nakamura R, Folkers K, Morrison RF. Study of periodontic disease and coenzyme Q. Res Commun Chem Pathol Pharmacol 1975 ; 11:265-71. View pilfer. Jolliet P, Simon N, Barre J, et alabama. Plasma coenzyme Q10 concentrations in breast cancer : prognosis and curative consequences. Int J Clin Pharmacol Ther 1998 ; 36:506-9. View abstract. Joshi SS, Sawant SV, Shedge A, Halpner AD. Comparative bioavailability of two novel coenzyme Q10 preparations in humans. Int J Clin Pharmacol Ther 2003 ; 41:42-8. View abstract. Kamikawa T, Kobayashi A, Yamashita T, et aluminum. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris pectoris. Am J Cardiol 1985 ; 56:247-51. View abstract. Keogh A, Fenton S, Leslie C, et alabama. Randomised double-blind, placebo-controlled trial of coenzyme Q, therapy in course II and III systolic heart failure. Heart Lung Circ. 2003 ; 12:135-41. View outline. Khatta M, Alexander BS, Krichten CM, et aluminum. The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med 2000 ; 132:636-40. View abstract. Kim J, Medsinge A, Chauhan B, et aluminum. Coenzyme Q10 in the treatment of corneal edema in Kearns-Sayre : is there an lotion in Fuchs endothelial corneal dystrophy ? Cornea. 2016 Sep ; 35 ( 9 ) :1250-4. View pilfer. Kim WS, Kim MM, Choi HJ, et alabama. Phase II discipline of high-dose lovastatin in patients with advance gastric adenocarcinoma. Invest New Drugs 2001 ; 19:81-3. View abstract. Kishi H, Kishi T, Folkers K. Bioenergetics in clinical music. III. inhibition of coenzyme Q10 enzymes by clinically used anti-hypertensive drugs. Res Commun Chem Pathol Pharmacol 1975 ; 12:533-40. View abstraction. Kishi T, Kishi H, Watanabe T, et alabama. Bioenergetics in clinical music. eleven. Studies on coenzyme Q and diabetes mellitus. J Med 1976 ; 7:307-21. View abstract. Kishi T, Makino K, Okamoto T, et alabama. prohibition of myocardial breathing by psychotherapeutic drugs and prevention by coenzyme Q. In : Yamamura Y, Folkers K, Ito Y ( eds ). biomedical and clinical aspects of coenzyme Q. Amsterdam : Elsevier/North-Holland Biomedical Press 1980 ; 2:139-54. Kishi T, Watanabe T, Folkers K. Bioenergetics in clinical medicate. fifteen. prohibition of coenzyme Q10 enzymes by clinically used adrenergic blockers of B-receptors. Res Commun Chem Pathol Pharmacol 1977 ; 17:157-64. View abstract. Laaksonen R, Jokelainen K, Sahi T, et alabama. Decreases in serum ubiquinone concentrations do not result in reduce levels in muscleman tissue during short-run simvastatin treatment in humans. Clin Pharmacol Ther 1995 ; 57:62-6. View abstract. Lampertico M, Comis S. Italian multicenter discipline on the efficacy and safety of coenzyme Q10 as accessory therapy in center failure. Clin Investig. 1993 ; 71 ( 8 Suppl ) : S129-33. View abstract. Landbo C, Almdal TP. [ Interaction between warfarin and coenzyme Q10 ]. Ugeskr Laeger 1998 ; 160:3226-7. View abstract. Langsjoen P, Willis R, Folkers K. Treatment of essential high blood pressure with coenzyme Q10. Mol Aspects Med 1994 ; S265-72. View abstract. Langsjoen PH, Langsjoen A, Willis R, Folkers K. Treatment of hypertrophic cardiomyopathy with coenzyme Q10. Mol Aspects Med 1997 ; 18 Suppl : S145-51. View abstract. Langsjoen PH, Langsjoen PH, Folkers K. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 1990 ; 65:521-3. View abstract. Langsjoen PH, Vadhanavikit S, Folkers K. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease. Drugs Exp.Clin Res 1985 ; 11:577-9. View abstract. LaValle JB. Hidden disruptions in metabolic syndrome : drug-induced food depletion as a pathway to accelerated pathophysiology of metabolic syndrome. Altern Ther Health Med. 2006 Mar-Apr ; 12 ( 2 ) :26-31 ; quiz 32-3. View abstract. Lee CK, Pugh TD, Klopp RG, et aluminum. The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life cross and gene expression patterns in shiner. free Radic Biol Med 2004 ; 36:1043-57. View pilfer. Lee YJ, Cho WJ, Kim JK, Lee DC. Effects of coenzyme Q10 on arterial severity, metabolic parameters, and fatigue in corpulent subjects : a double-blind randomized controlled study. J Med Food 2011 ; 14:386-90. View abstract. Lei L, Liu Y. Efficacy of coenzyme Q10 in patients with cardiac failure : a meta-analysis of clinical trials. BMC Cardiovasc Disor. 2017 Jul 24 ; 17 ( 1 ) :196. View abstract. Leong J. Y., vanguard five hundred Merwe J., Pepe S., Bailey M., Perkins A., Lymbury R., Esmore D., Marasco S., Rosenfeldt F. Perioperative metabolic therapy improves oxidation-reduction condition and outcomes in cardiac surgery patients : a randomized test. Heart Lung Circ 2010 ; 19 ( 10 ) :584-591. View abstract. Lerman-Sagie T, Rustin P, Lev D, et alabama. dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J Inherit Metab Dis 2001 ; 24:28-34. View abstract. Lesser GJ, Case D, Stark N, et alabama ; Wake Forest University Community Clinical Oncology Program Research Base. A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related tire in newly diagnosed patients with breast cancer. J Support Oncol. 2013 ; 11 ( 1 ) :31-42. View pilfer. Lewin A, Lavon H. The consequence of coenzyme Q10 on sperm motion and officiate. Mol Aspects Med 1997 ; 18 Suppl : S213-9. View abstract. Lister RE. An open, original study to evaluate the electric potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome. J Int Med Res 2002 ; 30:195-9. View abstract. Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dose of coenzyme Q10. Biochem Biophys Res Commun 1994 ; 199:1504-8. View abstraction. Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of front cancer with vitamin Q10 and the arrested development of metastases. Biochem Biophys Res Commun 1995 ; 212:172-7. View abstract. Lonnrot K, Porsti I, Alho H, et aluminum. Control of arterial tone after long-run coenzyme Q10 supplement in aging rats. Br J Pharmacol 1998 ; 124:1500-6. View abstract. Lund EL, Quistorff B, Spang-Thomsen M, Kristjansen PE. Effect of radiation sickness therapy on small-cell lung cancer is reduced by ubiquinone intake. Folia Microbiol ( Praha ) 1998 ; 43:505-6. View abstract. Ma A, Zhang W, Liu Z. Effect of protection and repair of wound of mitochondrial membrane- phospholipid on prognosis in patients with dilate cardiomyopathy. Blood Press Suppl 1996 ; 3:53-5. View abstract. Maguire Á, Mooney C, Flynn G, et aluminum. No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder : Results of a Randomized, Placebo-Controlled Trial. J Clin Psychopharmacol. 2021 ; 41 ( 1 ) :53-57. View abstract. Malm C, Svensson M, Ekblom B, et aluminum. Effects of ubiquinone-10 supplementation and gamey saturation trail on physical performance in humans. Acta Physiol Scand 1997 ; 161:379-84. View abstract. Marcoff L, Thompson, PD. The role of coenzyme Q10 in statin-associated myopathy : a systematic review. J Am Coll Cardiol 2007 ; 49:2231-7. View abstract. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, et alabama ; Huntington Study Group 2CARE Investigators and Coordinators. A randomize, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 ; 88 ( 2 ) :152-159. department of the interior : 10.1212/WNL.0000000000003478. View outline. Moradi M, Haghighatdoost F, Feizi A, Larijani B, Azadbakht L. Effect of coenzyme Q10 supplementation on diabetes biomarkers : a systematic review and meta-analysis of randomized control clinical trials. Arch Iran Med. 2016 ; 19 ( 8 ) :588-96. department of the interior : 0161908/AIM.0012. View abstract. Morisco C, Nappi A, Argenziano L, et alabama. noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure : effects of short-run coenzyme Q10 treatment. Mol.Aspects Med 1994 ; 15 Suppl : s155-s63. View outline. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure : a long-run, multicenter, randomized study. Clin Investig 1993 ; 71 : S134-6. View pilfer. Mortensen SA, Kumar A, Dolliner P, et aluminum. The effect of coenzyme Q10 on unwholesomeness and deathrate in chronic heart failure. Results from the Q-SYMBIO learn. european Journal of Heart Failure 2013 ; 15 : S1-20. Mortensen SA, Leth A, Agner E, et alabama. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med 1997 ; 18 : S137-44. View outline. Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, et alabama ; Q-SYMBIO Study Investigators. The effect of coenzyme Q10 on unwholesomeness and deathrate in chronic kernel failure : results from Q-SYMBIO : a randomize double-blind test. JACC Heart Fail. 2014 ; 2 ( 6 ) :641-9. View abstract. Mortensen SA, Vadhanavikit S, Muratsu K, Folkers K. Coenzyme Q10 : clinical benefits with biochemical correlates suggesting a scientific discovery in the management of chronic heart failure. Int J Tissue React. 1990 ; 12:155-62. View abstract. Munkholm H., Hansen H. H., Rasmussen K. Coenzyme Q10 treatment in serious heart failure. Biofactors 1999 ; 9:285-9. View abstract. Musumeci O, Naini A, Slonim AE, et alabama. Familial cerebellar ataxia with muscle coenzyme Q10 lack. Neurology 2001 ; 56:849-55. View outline. Naylor compact disk, O’Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic brain disorder. A meta-analysis. Gastroenterology 1989 ; 97:1033-42. View abstract. Orlando P, Silvestri S, Galeazzi R, et alabama. effect of ubiquinol supplementation on biochemical and oxidative stress indexes after acute exercise in young athletes. Redox Rep 2018 ; 23 ( 1 ) :136-45. department of the interior : 10.1080/13510002.2018.1472924. View outline. Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, et aluminum. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease : no attest of profit. JAMA Neurol. 2014 ; 71 ( 5 ) :543-52. View abstract. Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W. A randomized controlled trial of coenzyme Q10 for tire in the late-onset sequela of poliomyelitis. Complement Ther Med. 2015 Dec ; 23 ( 6 ) :789-93. View abstract. Pepping J. Coenzyme Q10. Am J Health-Syst Pharm 1999 ; 56:519-21. View abstract. Permanetter B, Rossy W, Klein G, et alabama. Ubiquinone ( coenzyme Q10 ) in the long-run treatment of idiopathic dilated cardiomyopathy. Eur Heart J 1992 ; 13:1528-33. View outline. Pizzorno JE, Murray MT, eds. Textbook of Natural Medicine. 2nd erectile dysfunction. New York : Churchill Livingston, 1999. Playford DA, Watts GF, Croft KD, Burke V. Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory affair in type 2 diabetes. atherosclerosis 2003 ; 168:169-79. View abstract. Portakal O, Ozkaya O, Erden Inal M, et aluminum. Coenzyme Q10 concentrations and antioxidant condition in tissues of breast cancer patients. Clin Biochem 2000 ; 33:279-84. View outline. Porterfield LM. Why did the response to warfarin change ? radon 2000 ; 63:107. View abstract. Postorino El, Rania L, Aragona E, et aluminum. efficacy of eyedrops containing cross-link hyaluronic acid and coenzyme Q10 in treating patients with meek to moderate dry eye. Eur J Ophthalmol. 2018 Jan ; 28 ( 1 ) :25-31. View abstract. Rengo F, Abete P, Landino P, et alabama. Role of metabolic therapy in cardiovascular disease. Clin Investig. 1993 ; 71 ( 8 Suppl ) : S124-S8. View abstraction. Rivara MB, Yeung CK, Robinson-Cohen C, et alabama. effect of coenzyme Q10 on biomarkers of oxidative tension and cardiac function in hemodialysis patients : the CoQ10 biomarker trial. Am J Kidney Dis. 2017 Mar ; 69 ( 3 ) :389-99. View abstract. Robbers JE, Tyler VE. Tyler ‘s Herbs of Choice : The Therapeutic Use of Phytomedicinals. New York, NY : The Haworth Herbal Press, 1999. Rosenfeldt F., Hilton D., Pepe S., Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, high blood pressure and affection failure. Biofactors 2003 ; 18:91-100. View abstract. Rotig A, Appelkvist EL, Geromel V, et aluminum. Quinone-responsive multiple respiratory-chain dysfunction due to far-flung coenzyme Q10 insufficiency. Lancet 2000 ; 356:391-5. View abstract. Rozen TD, Oshinsky ML, Gebeline CA, et aluminum. loose label test of coenzyme Q10 as a migraine preventive. Cephalalgia 2002 ; 22:137-41. View abstract. Rundek T, Naini A, Sacco R, et alabama. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 2004 ; 61:889-92.. View abstraction. Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the reduce form of coenzyme Q10 ( ubiquinol ) on semen parameters in men with idiopathic sterility : a double-blind, placebo controlled, randomized survey. J Urol. 2012 ; 188 ( 2 ) :526-31. View abstract. Safarinejad MR. Efficacy of coenzyme Q-10 on semen parameters, sperm function and generative hormones in sterile men. J Urol 2009 ; 182:237-48. View abstract. Sahebkar A, Simental-Mendía LE, Stefanutti C, Pirro M. Supplementation with coenzyme Q10 reduces plasma lipoprotein ( a ) concentrations but not other lipid indices : A taxonomic review and meta-analysis. Pharmacol Res. 2016 ; 105:198-209. department of the interior : 10.1016/j.phrs.2016.01.030. View abstract. Samimi M, Zarezade Mehrizi M, Foroozanfard F, et aluminum. The effects of coenzyme Q10 supplementation on glucose metamorphosis and lipid profiles in women with polycystic ovary syndrome : a randomize, double-blind, placebo-controlled trial. Clin Endocrinol ( Oxf ). 2017 Apr ; 86 ( 4 ) :560-66. View abstract. Sander S, Coleman CI, Patel AA, et alabama. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail. 2006 ; 12:464-72. View abstract. Sandor PS, Di Clemente L, Coppola G, et alabama. efficacy of coenzyme Q10 in migraine prophylaxis : A randomized controlled trial. neurology 2005 ; 64:713-5. View abstract. Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients : A double subterfuge randomized clinical test. Nutr Neurosci. 2016 ; 19 ( 3 ) :138-43. department of the interior : 10.1179/1476830515Y.0000000002. View abstract. Sazali S, Badrin S, Norhayati MN, Idris NS. Coenzyme Q10 supplementation for prophylaxis in pornographic patients with migraine-a meta-analysis. BMJ Open. 2021 ; 11 ( 1 ) : e039358. View abstract. Serra G, Lissoni F, Piemonti C, et aluminum. evaluation of coenzyme Q10 in patients with moderate heart failure and chronic stable attempt angina. In : Folkers K, Littaru GP, and Yamagami T. Biomedical and clinical aspects of coenzyme Q. Amsterdam : Elsevier Science Publishers ; 1991. Serrano-Morales JM, De-Hita-Cantalejo C, Sánchez-González MC, Bautista-Llamas MJ, Sánchez-González JM. Efficacy of 0.1 % crosslinked hyaluronic acid, coenzyme Q10 and vitamin east in the management of dry eye disease in menopause patients receiving antidepressants. Eur J Ophthalmol. 2020:1120672120972026. View abstract. Shanmugasundaram ER, Rajeswari G, Baskaran K, et aluminum. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol 1990 ; 30:281-94. View abstract. Shoeibi A, Olfati N, Soltani Sabi M, Salehi M, Mali S, Akbari Oryani M. Effectiveness of coenzyme Q10 in contraceptive treatment of migraine concern : an open-label, accessory, control trial. Acta Neurol Belg. 2017 Mar ; 117 ( 1 ) :103-109. department of the interior : 10.1007/s13760-016-0697-z. View pilfer. Shults CW, Beal MF, Fontaine D, et alabama. Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients. Neurology 1998 ; 50:793-5. View outline. Shults CW, Oakes D, Kieburtz K, et alabama. Effects of coenzyme Q10 in early Parkinson disease : evidence of slow of the running descent. Arch Neurol 2002 ; 59:1541-50. View abstract. Singh RB, Neki NS, Kartikey K, et alabama. effect of coenzyme Q10 on hazard of atherosclerosis in patients with late myocardial infarct. Mol Cell Biochem 2003 ; 246:75-82. View abstract. Singh RB, Niaz MA, Rastogi SS, et aluminum. effect of hydrosoluble coenzyme Q10 on rake pressures and insulin resistor in hypertensive patients with coronary artery disease. J Hum Hypertens 1999 ; 13:203-8. View outline. Skarlovnik A, Janic M, Lunder M, Turk M, Sabovic M. Coenzyme Q10 supplement decreases statin-related mild-to-moderate muscleman symptoms : a randomized clinical study. Med Sci Monit. 2014 Nov 6 ; 20:2183-8. department of the interior : 10.12659/MSM.890777. View abstract. Sobreira C, Hirano M, Shanske S, et alabama. Mitochondrial encephalomyopathy with coenzyme Q10 lack. Neurology 1997 ; 48:1238-43. View abstraction. Soja AM, Mortensen SA. treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol Aspects Med 1997 ; 18 : S159-68. View abstract. Soltani R, Alikiaie B, Shafiee F, et aluminum. Coenzyme Q10 improves the survival and reduces inflammatory markers in septic patients. Bratisl Lek Listy 2020 ; 121 ( 2 ) :154-8. View abstract. Soongswang J, Sangtawesin C, Durongpisitkul K, et alabama. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children. Pediatr Cardiol 2005 ; 26:361-6. View abstract. Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994 ; 334:1372-3. View abstract. Stojanovic M, Radenkovic M. A meta-analysis of randomized and placebo-controlled clinical trials suggests that coenzyme Q10 at low drug improves glucose and HbA1c levels. Nutr Res. 2017 Feb ; 38:1-12. View abstract. Storch A, Jost WH, Vieregge P, et alabama. Randomized, double-blind, placebo-controlled trial on diagnostic effects of coenzyme Q10 in Parkinson disease. Arch Neurol 2007 ; 64:938-44. View abstract. Suksomboon N, Poolsup N, Juanak N. Effects of coenzyme Q10 supplement on metabolic profile in diabetes : a systematic review and meta-analysis. J Clin Pharm Ther. 2015 Aug ; 40 ( 4 ) :413-8. View outline. Suzuki S, Hinokio Y, Ohtomo M, et alabama. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial deoxyribonucleic acid 3243 ( A to G ) mutation. Diabetologia 1998 ; 41:584-8. View outline. Taggart DP, Jenkins M, Hooper J, et aluminum. Effects of short-run supplementation with coenzyme Q10 on myocardial protection during cardiac operations. Ann Thorac Surg 1996 ; 61:829-33. View abstract. Tan JT, Barry AR. Coenzyme Q10 supplementation in the management of statin-associated myalgia. Am J Health Syst Pharm. 2017 ; 74 ( 11 ) :788-93.15. department of the interior : 10.2146/ajhp160714. View abstract. Tang G, Serfaty-Lacrosniere C, Camilo ME, et aluminum. Gastric sourness influences the blood response to a beta-carotene dose in humans. Am J Clin Nutr 1996 ; 64:622-6. View outline. Taylor BA, Lorson L, White CM, Thompson PD. A randomize trial of coenzyme Q10 in patients with confirmed lipid-lowering medicine myopathy. Atherosclerosis. 2015 Feb ; 238 ( 2 ) :329-35. department of the interior : 10.1016/j.atherosclerosis.2014.12.016. Epub 2014 Dec 17. View outline. Teran E, Hernandez I, Nieto B, et alabama. Coenzyme Q10 supplementation during pregnancy reduces the risk of preeclampsia. Int J Gynaecol Obstet 2009 ; 105:43-5. View abstraction. The Huntington Study Group. A randomize, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington ‘s disease. Neurology 2001 ; 57:397-404. View outline. The NINDS NET-PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early on Parkinson disease. Neurology 2007 ; 68:20-8. View abstract. Thibault A, Samid D, Tompkins AC, et aluminum. Phase I study of lovastatin, an inhibitor of the mevalonate nerve pathway, in patients with cancer. Clin Cancer Res 1996 ; 2:483-91. View pilfer. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003 ; 289:1681-90. View abstract. Toth S, Sajty M, Pekarova T, et alabama. addition of omega-3 fatty acid fatso acid and coenzyme Q10 to statin therapy in patients with compound dyslipidemia. J Basic Clin Physiol Pharmacol. 2017 Jul 26 ; 28 ( 4 ) :327-336. View abstract. Tran MT, Mitchell TM, Kennedy DT, Giles JT. Role of coenzyme Q10 in chronic heart failure, angina, and high blood pressure. Pharmacotherapy 2001 ; 21:797-806. View abstract. Turunen M, Olsson J, Dallner G. Metabolism and affair of coenzyme Q. Biochim Biophys Acta 2004 ; 1660:171-99. View abstract. Watson PS, Scalia GM, Galbraith A, et alabama. Lack of consequence of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1999 ; 33:1549-52. View abstract. Watts GF, Castelluccio C, Rice-Evans C, et aluminum. Plasma coenzyme Q ( ubiquinone ) concentrations in patients treated with simvastatin. J Clin Pathol 1993 ; 46:1055-7. View abstract. Watts TLP. Coenzyme Q10 and periodontic treatment : is there any beneficial effect ? Br Dent J 1995 ; 178:209-13. View abstract. Weis M, Mortensen SA, Rassing MR, et aluminum. Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers. Mol Aspects Med 1994 ; 15 : s273-80. View abstract. Welch KM. current opinions in concern pathogenesis : introduction and deduction. Curr Opin Neurol 1998 ; 11:193-7. View pilfer. Weston SB, Zhou S, Weatherby RP, Robson SJ. Does exogenous coenzyme Q10 involve aerobic capacity in survival athletes ? Int J Sport Nutr 1997 ; 7:197-206. View abstraction. Weyer G, Babej-Dolle RM, Hadler D, et aluminum. A control study of 2 doses of idebenone in the treatment of Alzheimer ‘s disease. Neuropsychobiology 1997 ; 36:73-82.. View pilfer. Wilkinson EG, Arnold RM, Folkers K, et aluminum. Bioenergetics in clinical medicine. II. Adjunctive treatment with coenzyme Q in periodontic therapy. Res Commun Chem Pathol Pharmacol 1975 ; 12:111-23. View pilfer. Wilkinson EG, Arnold RM, Folkers K. Bioenergetics in clinical medicine. VI. Adjunctive treatment of periodontic disease with coenzyme Q10. Res Commun Chem Pathol Pharmacol 1976 ; 14:715-9. View abstract. Yamagami T, Takagi M, Akagami H, et aluminum. effect of coenzyme Q10 on essential high blood pressure, a double blind controlled analyze. In : Folkers KA, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q, Vol. 5. amsterdam : Elsevier Science Publications, 1986:337-43.

Zhang P, Yang C, Guo H, Wang J, Lin S, Li H, et alabama. treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic visibility in dyslipidemic individuals. J Clin Lipidol. 2018 ; 12 : 417-427. department of the interior : 10.1016/j.jacl.2017.12.006. View abstract. Zhao Q, Kebbati AH, Zhang Y, Tang Y, Okello E, Huang C. Effect of coenzyme Q10 on the incidence of atrial fibrillation in patients with heart bankruptcy. J Investig Med. 2015 Jun ; 63 ( 5 ) :735-9. department of the interior : 10.1097/JIM.0000000000000202. View abstract. Zhu ZG, Sun MX, Zhang WL, Wang WW, Jin YM, Xie CL. The efficacy and condom of coenzyme Q10 in Parkinson ‘s disease : a meta-analysis of randomized master trials. Neurol Sci 2017 ; 38 ( 2 ) :215-224. View abstract .

informant : https://nutritionline.net
Category : Healthy